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A.

Author's prefac,:
When I came to the U.S.A., I received training as an
anesthesiologist and later was employed in this capacity.
For a research-minded anesthesiologist, two avenues of investigation seemed natural; either research on physiology
and pharmacology of respiration or research on the problem
of neuromyal transmission.
Many anesthesiologists have done work on the nervemuscle junction and contributed not only to applied pharmacology of muscle relaxants, but also to the understanding of
the mechanisms of neuromyal cholinergic transmission. It
should suffice to mention such anesthesiologists and authors
of many research papers and important texts as F. Foldes, V.
Collins, R. D. Dripps, H. C. Churchill-Davidson. My special
interest in the neuromyal junction was aroused by the reading
of their stimulating publications as well as by the baffling
and protean behavior of the nerve-muscle transmission. No
"
one who practices anesthesia oould help but be challenged
and
mystified by the variable sensitivity and the qualitative
change of the response of the endplate to neuromyal agents.
Moreover, we deal here with a very basic physiological mechanism _ that of cholinergic transmission. Altogether, the
temptation to study the versatility of this transmission at
the neuromyal site cannot be easily resisted. This explains
why, along with anesthesiologists, many prominent neurophysiologists and neuropharmacologists either have made the neuromyal junction the subj ect of tneir main iJl~eoccupation, as did
B. Katz, P. Fatt, G. L. Brown, S. W. Kuffler, S. Thesleff,
E. Zaimis, or at least attacked this subject at one time or
another, as exemplified by J. C. Eccles, D. Bovet, G. B.
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Koelle, K. R. W. Unna, J. Hoppe, and others.
When, therefore, the chance was offered to me to be trained
in the methodology of studying neuromyal transmission by Dr.
K. Koketsu and to carry out research for a Ph.D. in this area
under Dr. A. G. Karczmar, I could not but embrace this chance.

2.

B.

Iptroduction

I. PhYsiOlogy of the neuromyal ,iunctio~.
1. Historical developments leading to the modern
concepts of neuromyal physiology.
Before the latter half of the nineteenth century it was
assumed that a continuity exists between nerve and muscle (cf.
Brazier, 1959). The muscle was supposed to be activated by a
nervous fluid, possibly having properties of Newtonls ether,
which could fill the muscle and provide its tension and rigidity.
In 1862 Kuehne (cf. also Kuehne, .1888) noted histological
differences between skeletal muscle and its innervation. He
suggested that the action current of the nerve, discovered previously by Du Bois-Reymond (1848, 1849). invaded the muscle
and caused it to contract. Du Bois-Reymond noticed a transbolt h0 \l.Ah
mission delay at the neuromyal junotion;Aat first
he
/\
l~tet
considered that it may be due to chemical influences, he beIt
lieved that electrical fields of a nerve-muscle continum were
"
responsible for contraction.
The importance of the junction was established by the
researches of Claud& Bernard (1857), which indicated that
curare acts at a peripheral site on the motor nerve. Subsequently Langley (1905, 1907) showed that nicotine can act,
upon denervacion and motor nerve degeneration, at restricted
sites vf the muscle fiber.
At the turn of the century the concept of the chemical
nature of neuromyal transmission was elaborated by Elliott
(1905), Dale (cf. his Harvey Lecture, 1937), and Loewi (1921).
Their work dealt ~rincipally with smooth and cardiac muscle.
The thought that transmission at the parasympathetic nerve

endings is cholinergic in nature, originated from Dixon's (1907)
suggestion that the transmitter may be muscarine, an alkaloid
related to choline. Subsequently, acetylcholine (ACh) was implicated as a transmitter substance (Hunt and Taveau, 1906;
Dale, 1914; Loewi, o.c.) at parasympathetic nerves. Finally,
Dale and his associates (cf. Dale, Feldberg and VOL~; 1936)
showed that motor nerve terminal releases upon stimUlation a
pharmacologically active substance, later identified as ACh.
This classical period of the studies of cholinergic transmission and of the neuromyal junction terminated with the studies of Sir Lindor Brown (1937,and with Dale, Feldberg, and
Vogt, 1936) in which they showed that "closel! (1) intra-arterial injection of ACh mimics, in both innervated and denervated muscle, the effects of nerve impulse; this was true with
regard to mechanical and membrane responses of the musle. It
could be also shown that curare and physostigmine influence
mechanical and membrane effeQts of injected ACh just as they
do the responses of the stimulation of the motor nerve. Thus,
the transmitter rola of ACh at the motor nerve terminal was
additionally substantiated by the similarity of the effects of
drugs upon the muscle response to ACh, on one hand, and to motor
nerve stimUlation on the other.
Altogether, we can consider that by the 1940's not only
the neuromyal transmission was proven to be cholinergic in
nature, but also the importance of the endplate (e.p.), while
(1) "Close" intra-arterial injection is a pharmacological term.
In this technique, the agent is injected into the artery as
close as possible to its presumed site of action.

originating from the nineteenth century researches of Kuehne
(o.c.), and Bernard (o.c.), was finally established as an ACh
receptor. Both these achievements can be attributed mainly to
the English school of investigators (Brown, Feldberg, Dale, and
Eccles; cf. EcOl es, Ka-tz; and Kuffler, 1941).
2. Physiological events at the endplate.
a. Morphology of the endplate. The work of Couteaux (1947, 19~5) established that "there are three sharply
defined components of different cellular origin at the junction"
(Fatt, 1959). The first of these is the terminal apparatus of
the nerve; the second - the specialized region of muscle surface
contacted by the nerve endings; the third - a layer of neuroglia,
which at this site is referred to as teloglia, continuous with
the Schwann cell envelope of the myelinated fiber. The teloglia
contributes half the nuclei of the junctional region (the sole
nuclei), the remainder being the fundamental nuclei in the
muscle, and acco~panies the nerve terminals as they sink into
t~e grooves in the muscle fiber surface.
Muscle fibers lining
the groove form infoldings, as seen in the electron microscope
(Robertson, 1956; Andersson-Cedergreen, 1959). While the
picture of the junction as described above is generally
characteristic for all species, there are differences between
the mammalian and frog ("bush" endplate) junctions, the mamma1iat
e.p. occupying a smaller site in relation to the muscle, while
the nerve terminals of the frog endbush cover a wide area of the
muscle fiber.
Most recently, an interesting contribution to the anatomy
of the nerve terminal portion of the junction was offered by
De Robertis (1958) and confirmed by Andersson-Cedergreen (1959)
and other investigators. These investigators showed occurrance
at the terminal nerve endings of small vesicular elements,
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called synaptic vesicles. Indirect evidence (cf. Del Castillo
and Katz, 1956a; and Eccles, 1958) suggests that synaptic
vesicles contain ACh, presumably in the quantal form of
"packages" (cf. also below).
b. Cholinesterases and the neuromyal junction.
It was shown in a series of researches by Nachmansohn and
his associates (Marnay and Nachmansohn, 1938; Nachmansohn, 1940;
cf. also Nachmansohn, 1946 and 1959) that cholinesterase (ChE)
is an enzyme concentrated at the endplate. In terms of the
kinetics of its action, ChE can account for the almost instantaneous hydrolysis of ACh, released ~t the nerve terminals. The
rapidity of the action of ChE is a pre-requisite, as proposed
by Nacbmansohn, for functionab111ty of the neuromyal junction.
The importance of ChEfs for the function of the neuromyal
junction and of other synapses has been further extended by
many investigators (for recent review, cf. Koelle, 1961a and b).
While their specific function will be reviewed more in detail
in subsequent sections of this introduction, it should be stated
at present in general terms that chemical transmission may depend
not only on the presence of a transmitter, but also upon the
availability of a hydrolytic enzyme (Loevi, 1921, Giarman, 1957).
In view of this, and particularly because of their role in the
neuromyal function, the localization of ChE's in the junction
is important.
The ChE of the endplate is predominatly acetyl-cholinesterase (AChE), located mostly post-synaptically_ Pseudocholinesterase (butyrylcholinesterase, BuChE) is present in smaller
quantities (Denz, 1953; Holmstedt, 1957 and 1959). AChE is
present also at the musculotendinous junctions. Some AChE or
BuChE is present in the muscle fiber (Becket and Bourne, 1957).
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It should be stated here that a physiologically and
functionally important difference between AChE and BuChE is
that the former is a faster and a more specific enzyme. As
stated by Nachmansohn (o.c.), this enzyme, rather than BuChE,
fullfills the criteria of an enzyme capable of terminating
the actions of ACh. On the other hand, BuChE may be concerned
with terminating the action of exoesses of aoetyloholine esoaping into the blood stream (Koppanyi and Karozmar, 1953). In
acoordance with this difference between the two ChEws, AChE
predominates in central and peripheral synapses, and BuChE in
the blood and in certain barriers surrounding synapses (Volle
and Koelle, 1961).
c. Eleotrioal response at the e.p. and at the
nerve terminal.
It was shown first by Eooles and O'Connor (1938) and
Shaetter and Haass (1939) that a non-propagated negative, monophasio potential arises in a curarized, non-contraoting musole.
This potential, charaoterized by a brief rising phase and a
slower return to the baseline, is referred to as the endplate
potential (e.p.p.); it is focused at the nerve endings, and
magnitude-wise correlated with their density (Ecoles, Katz and
Kuffler, 1941 and 1942). Upon reduotion of the ooncentration
of ourare, action potentials of individual fibers appear as
defleotions superimposed on the e.p.p., till a full, synchronize1
aotion potential obsoures the e.p.p. oompletely. To the contrary. when the concentration of curare is inoreased, the e.p.p.
becomes reduoed.
Fatt and Katz (1951) used the intraoellular recording
technique to study the e.p.p.'s at the individual musole
fibers as potentials obtained across the fiber membrane at the

position of insertion of the electrode. By means of this
technique the frog muscle fiber was found "to have a resting
membrane potential of above 90 mv (inside negative with respect
to outside), which is the same in the junctional region as
elsewhere along the fiber" (Fatt, 1959). In a frog nervemuscle preparation, critically curarized to abolish contraction,
muscle fibers display, in response to nerve stimulation, e.p.p.'
s ranging from 10 to 40 mv. The e.p.p. is, ill these conditions,
a transient positive deflection, or reduction of membrane
potential from its resting level (depolarization). The e.p.p.
becomes attenuated and slower when measured progressively
further away from the llerve terminal.
Threshold depolarization of 40 mv initiates the propagated,
biphasic action potential. The spike portion of the action
potential is the positive deflection of membrane potential, indicating depolarization, plus the overshoot or the reversal of
the membrane potential. The spike at the e.p. differs in certain features from the spike evoked in the musole fiber by
direct stimulation. This may be due to the modification of
the action potential by junotional aotivity. This aotivity
consistently causea a deviation toward a level near zero membrane potential (Fatt, 1959). On the basis of further biophysical and experimental analysis, Fatt conoluded that "the
effect of junotional aotivity on the muscle fiber membrane oan
be represented as the addition of a conductance in a series
with a fixed emf. This may further be interpreted as the
creation of a new path for the diffusion of ions across the
membrane" (0.0.).
While the above description of the e.p.p. is based on
investigations of amphibian muscle fibers, it also applies,
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exoept for oertain numerical and pattern differenoes, to mammalian muscu~ature. The differences are due to a higher oonductanoe of the latter, with a consequent reduotion in eleotric
time and spaoe constants.
An important aspect of ACh as the transmitter substanoe
at the neuromyal junction is, as already stated» its behavior
when applied to the junctional tissue. Whether applied to the
whole muscle fiber, or only to the area invaded by the nerve
endings, ACh depolarizes the junotional region alone (Cowan,
1936; Kufflar, 1943; Burns and Paton, 1951). This can be demonstrated by means ot iontophoretic technique, in which ACh
is applied by means of brief eleotric pulses from a micropipette.
In this case, ACh was found to be ineffective along the whole
musole fiber (Nastuk, 1953; Del Castillo and Katz, 1955a).
When amphibian musole is exposed in the presence of ChE inhibitors to ACh, the concentration of ljlM depolarizes the
junotional region suffioiently to produce a spike. With lower
oonoentrations, depolarization is progor-tional to the amount
of ACh. With higher concentration, depolarization persists
after a number of spikes, at the time when the neuromyal juncticn
is not capable of further initiation of spikes. The viewpoint
that ACh acts on the e.p. alone was recently attacked by Ochs
at ale (1959), but even more reoent findings of Katz (1959) seem
to support the original contention that chemical sensitivity
of the muscle i3 restricted. High sensitivity to ACh extends
only over very limited regions in the neighborhood of the nerve
terminal branches; in the frog, the sensitivity decreases or
disappears already within 10 to 20 ~ from the nerve terminal.
Recently, Miledi (1960) thought that this region, while limited.
extends somewhat further. Depolarization occurs only when ACh
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is applied to the fiber surfaoe; ACh is not effective when released within the musole fiber. ~he time course of depolarization, while much longer than that of e.p.p., is consistent
with the reasonable assumption that ACh must diffuse from its
point of release to the reoeptor some microns away. Finally,
depolarization elicited by ACh can be demonstrated (Del Ca&til10 and Katz, 1955b) to be caused by the same oonductance
change which oocurs during transmission.
The appearance, during quiescence of the nerve, of small
(0.5 my) transient changes of potential (miniature endplate
potentials, m••• p.p.), has an interesting bearing on neuromyal
transmission. The m.e.p.p.'s e~re~ in a small way, the
characteristios of the e.p.p.'s. they have a similar time
oourse, are attenuated away from the nerve terminals, and are
affected like e.p.p.'e by oertain drugs, such as curare and ChE
inhibitors. The m.e.p.p.'s disappear upon denervation and
subsequent degeneration of the nerve terminal. This and other
considerations caused Fait (1959) in partioular to consider
m.e.p.p.'s as being due to random collisions of the synaptic
vesicles, already described as probably containing "packages"
of ACh, with active sites in the nerve terminal membrane; these
oollisions would lead to release of "quanta" of AOh, and to
depolarization at restrioted receptor sites. The normal e.p.p.,
or the spike, depends on the other hand, on synohronized release of a very large number ot "paokages", leading to a oonstant spike amplitude. Not neoessarily the same vesioles disoharge per eaoh spike, although their number, per eaoh spike,
is oonstant. On the other ha.nd, an incomplete disoharge of
relatively tew vesioles would lead to a reduoed e.p.p., and
finally to a m.e.p.p.

10 ..
Some of the lines of indirect eVidence for this viewpoint are as follows; first, withdrawal of calcium reduces the
size of the e.p.p., till the e.p.p. becomes not much larger
than the m.e.p.p.; it also fluctuates in size and can become
intermittent (Boyd and Martin, 1956a and b; Del Castillo and
Katz, 1954aj Liley, 1956). This is because (Fatt, 1959) the
e.p.p. reveals itself under these conditions as being composed
of a variable number of m.e.p.p.t s , the fluctuation being due
to variation in number of units firing. Seoond, when trains
of stimuli are used in the frog nerve muscle preparation, the
second stimulus leads to a larger e.p.p. When the calcium
concentration is reduced so that the e.p.p. has an amplitude
corresponding to postulated discharge of a few synaptic vesicles as described before, the response to the second of the
stimuli is again increased, and, what is most important, the
fluctuation is reduced. This reduction of fluctuation can be
due only to an increase in the number of units, or of synaptic
vesicles, responding (Del Castillo and Katz, 1954b).
d. Mechanism of neuromyal transmission.
From various experiments described above, the amount of
ACh released during a single nerve impulse at a single junction
has been calculated as 10-18 moles (Emmelin and McIntosh, 1956).
This figure, after certain corrections are made, corresponds
well to the minimal quantity of ACh, applied iontophoretically,
capable of evoking spike upon application to the endplate.
ACh, released during the single impulse, is presumably
liberated by concerted breakage of a constant (per each
impulse) number of synaptic vesicles in the nerve terminals.
It can be also calculated that ACh will exert its maximal
effect before diffusing more than 1 f, a
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distance which agrees with the morphological, electron microscope findings on the separation of the pre- and post-junctional surfaces. Finally, ACh will remain in effective concentration at the junction for less than 1 ms, and diffusion
will terminate the first, high intensity transmitter action,
expressed by the short duration of the rising phase of the
e.p.p., or of the spike. On the other hand, desoending phase
of the e.p.p. will depend on factors other than the movement
of ACh, for instanoe, on the activity of AChE (Fatt, 1959).
Finally; upon combining with the receptor, ACh alters physical
properties of the membrane and a new path appears for ionic
diffusion; in eleotrical terms, an additional conductance
short circuits existing potential differences. These concepts,
when considered jOintly with Grundfestfs (1957; 1959) concept
of electrical non-excitability of perhaps most synapses; lead
to a picture of the skeletal neuromyal junction as one of the
most explored, chemically operated synapses.
II. Pharmacology of the neuromyal junction.
1. General concepts.
Certain aspects of pharmacology of the neuromyal junction
have been already presented, since they form an integral part
of our concepts of the neuromyal transmission. Conversely,
certain drug actions can be deduced from the knowledge of the
physiology of the e.p. Thus, curare and its crystalline disomer, d-tubocurarine (d-Thc), does not by itself affect
electric properties of the membrane, but prevents ACh from
combining with the receptor and from exerting the depolarizing
action. ACh and d-Tbc interact competitively and the e.p.p.
will be decreased by large concentrations of d-Tbc because
under these circumstances depolarization will not suffice
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to produoe the spike and also it will embraoe only relatively
few receptor units (Bovet, 1951). A number of synthetio substanoes share the properties of d-Tbc (Bovet, 1951 and 1959;
Hoppe, 1957). On the other hand, ChE inhibitors, while inoapable of affecting the early phase of ACh action, may cause
ACh acoumulation at the a.p., ACh then becoming oapable of
displacing d-Tbc (Pelikan et al., 1956). By means of a similar
mechanism, anti-ChE agents can inorease the amplitude and
possibly the frequenoy of m.e.p.p. 's, and prolong the e.p.p.
(Del Castillo and Katz, 1954c); finally, in the presence of
anti-ChE agents, single motor nerve ~t1mulation will lead to
repetitive firing rather than to single spike (Nastuk and
Alexander, 1954. Karczmar and Fudema, 1957; Karczmar, 1961).
Repetitive firing is acoompanied by the maoroscopically observable sustained oontraction, indistinguishable from the
tetanio twitch whioh is normally obtain9d upon repeated disoharge.
Finally, oertain substanoes whioh resemble ACh, oan depolarize the e.p. similarly to the transmitter substanoe. These
do not have to be choline esters, but must exhibit a cationio.
usually quaternary head of oertain electron density, the latter
depending in part on the dimension of the quaternary or related
radioal (Riker, 1953, Riker et al., 1958). Among the most
effective depolar1zers are two bisquaternaries, decamethonium
(010 ) and succinylcholine (SOh; Paton and Zaimis, 1949; Ginzel
et al., 1951). Anti-ChE agents, presumably because of protection they afford ACh, can also depolarize (Douglas and Paton,
1954); this depolarization ca.n oocur only in the presence
large conoentrations of the anti-OhE agents.
of
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It is of interest that certain ~hemical resemblance exists
between many an ti-ChE agent s, depolarizers i:::wd cU,L'aremimet ics
(Karczmar,

..L 961;

Karczmar et 0,1., 1961).

In fact, many neuro-

myally active agents cannot be easily classified from the
pharmacological viewpoint; they may exhibit predominantly the
actions chara0teristic for one type of drugs, and, somewhat
less extensively, those characteristicS for drugs of another
type.

Thus, certain curaremimetics as well as many cholino-

mimetics may have anti-ChE action (Hoppe, o. c. ) .
may indicate certain similarities between

'rhis, in turn,

~holinergic

receptor

and the ChE or particularly AChE moiety: (Karczmar, 1961; Karczmar et al., o.c.).
2. Neuromyal blocking agents and their antagonists.
a. Curare, ammonium ions and anti-ChE agents .
.Lhe mechanism of action of curare, d-Tbc, and of synthetic
curaremimetics was discussed when basic properties of the e.p.
were described (cf. above).

As competitive antagonists of ACh,

these agents can be antagonized by large doses or concentrations
of ACh and of other depolarizing agents, principally quaternary
ammonium compounds.

Among the latter can be listed the phenyl""

trimethylammonium group investigated by Riker, Wescoe and their
associates (cf. Wescoe et al., 1949, 1950; Riker et al., 1957,
1959a).

Riker (1953) is of the opinion that these compounds

act as anticurare agents not only by depolarization but also
because they displace curare from the e.p., thus exposing
curare to metabolic destruction.

This hypothesis of displace-

ment was originally proposed by A. J. Clark (1933).
Riker's evidence for this concept is as follows.
dose of curare or d-Tbc, used alone, may produce a

Part of

The effective

Y2

hr.

blockade (cat data); depolarizing or excitatory action of

phenyltrimethylammonium compounds, as evidenced by repetitive
discharges, is, on the other hand, brief. Yet, when d-Tbc is
antagonized by a trimethylammonium compound, the blockade does
not recur.
The effect of anti-ChE agents is, as already indicated,
similar to that of large doses of ACh. In fact, Unna and his
associates (Unna et al., 1944; Pelikan, Smith and Unna, 1956)
could relate anticurare potenoy of a number of anti-ChE agents
to the enzymio inhibitory potenoy of the latter. However, in
the oase of at least these anti-ChE agents, whioh possess a
quaternary cationic head resembling t~at of trimetyl-ammonium
compounds or of ACh itself, their potency to displaoe d-Tbo
and also to produoe the depolarization of the e.p. plays also
a part in their anti-d-Tbc action. Prime examples are Edro phonium (Tenailon), and neostigmine (Prostigmine). Perhaps
among the first investigators to point out the differenoe
between the action of neostigmine and that of other anti-ChE
agents were Jacobsohn and Kahlson (1938). For instance 1
neostigmine but not other anti-ChE agents, oan produoe musole
twitoh in the cat upon close intra-arterial injeotion, and
its anti-curare effect is more prompt than that of physostigmine or phosphonate anti-ChE agents (Riker, 1953).
However,
whether acting solely by AChE inhibition, or also direotly,
this group of curare antagonists provokes repetitive firing
at the e.p., and oauses potentiation of the mechanical response of the muscle to indirect stimUlation.
b. Unstabilizers of motor nerve terminal and
curare.
Masland and Wigton (1940) and Eccles et al. (1942) demonstrated that upon administration of neostigmine and physo-
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stigmine short trains of repetitive antidromic discharges
can be made to appear in motor nerve fibers stimulated with
sir.t.gle or double shocks. More reoently, Riker, Werner and
their assooiates (Riker et al., 1957, 1959a and 1959b) studied
a number of oompounds, whioh are substituted trimethylammoniums
charaoterized particularly by a hydroxy substitution, but also
by substitutions of larger alkyl groups for the methyls of the
parent oompound. Riker and Werner stressed their presynaptic,
motor nerve terminal site of action. It is Riker's opinion
that these compounds are not anti-ChE agents, that they do not
depolarize, and that they produoe rep~titive firing and twitch
potentiation by unstabi11zation of the nerve terminal. Since
anti-ChE agents, physostigmine and neostigmine, also produce
antidromic firing, and since oertain trimethylammonium compounds and their analogs (such as Edrophon1um) exhibit antiChE potency (Nastuk et al., o.c.), it cannot be ruled out that
hydroxy alkyl ammonium agellts may unstabilize the nerve terminal
because of their anti-ChE action. It would be difficult to
prove this. Compounds of this struoture would presumably
inhibit reversibly cholinesterase aotion and this inhibition
oannot be readily demonstrated ~ vivo (Karozmar, 1961).
~asaki (1958) used mioroeleotrode methods on the e.p. of a
cephalopod (these animals are partioularly convenient for this
type of study), and he measured direotly the pre- and postsynaptio potentials. It is possible that his method should
be used to test further the hypothesis of Riker and his
assooia.tes.
It should be pointed out tha.t Koelle and his assooiates
(Koelle, 1961a and b; Volle and Koelle, 1961) post~lated
reoently that ACh itself can exert a retrograde action at the
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nerve terminal causing more release of ACh from its storage;
while Koelle's postulate was derived from data dealing with
a sympathetic ganglion, it may be extended to the neuromyal
junction. Altogether, it may well be that some agents,
whether cholinomimetic or anti-ChE in nature, or, finally,
methylammonium derivatives, may produce excitatory and anticurare effects at the e.p. by virtue of their nerve terminal
site of aotion. This action may be facilitatory in some, at
present, undefined way, or it may be due to release of ACh from
presumably synaptic vesiole. in the nerve terminal.
c. Aotion of tetraethyl~onium (TEA) and Sodium
Fluoride (BaF.).
aecently stovner (1957a, band c f 1958a, b, and c) and
Koketsu (1958) have studied still another anti-curare substance
TEA. Stovner (o.c.), studied mostly the effects of TEA upon
the blookade of neuromyal junction by curaremimetio substanoes.
Koketsu (0.0.), pointed out that, paradoxioally, TEA blocked
ACh depolarization very muoh like a ouraremimetio, and yet
antagonized d-!bc. They sugge.!e4 that, somewhat like hydroxymethylammonium oompounds, TEA. acts presynaptically, and possibll
releases ACh at that site. This interesting suggestion is
based on indirect information and deserves further evaluation.
An interesting feature of the aotion of TEA is that its
main effeot is the augmentation of the a.p.p. While TEA causes
some prolongation of the a.p.p., it does 80 to a much lesser
extent than anti-ChE agents (Koketsu, 1958). A chemically
unrelated compound, HaF, shares these characteristios with
TEA (Koketsu and Gerard, 1956). These and other features of
NaF action led these investigators to oonclude that, without
being an anti-ChE, it sensitizes the e.p. to ACh (0.0.).
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d. Depolarizing sub8~ano.s.
Burns and Paton (Burns and Paton, 1951; Paton, 1952)
compared depolarizing e.p. aotions of AOh and of decamethonium
(ClO) on the cat graoilis musole. In both oases, depolari~ation was oonfined to the e.p., but it was more or less per~i8tent only in the case of 0
10 • Depolarization by 010 re~embled that by ACh, provided the musole was pretreated with
physostigmine. In both oases, the depolarization rendered
~he e.p. but not the musole elsewhere eleotrioally inexoitable.
These experiments were extended by Zaimis and Paton (Za1mis,
1953 and 1959; Paton and Zaimis, 1949 and 1952). In 1952-1953
Zaimis was responsible for interesting oonoeptualization that
depolarizing agents can be effeotive, provided they are long
aoting, as blooking agents. Aooording to this hypothesis,
all pharmaoologio actions of depolarizers - musole twitoh
~pon i.a. administration as well as initial potentiation and
subsequent blockade of neuromyal transmission - are interre~ated and are the r$sult of their capacity to depolarize the
e.p. At that time then, two 01&$s8s of blooking substanoes
~ere distinguished, the oompetitively aoting ouraremimetios
on one hand, and the depolarizing blooking agents, exemplified
by suooinyloholine (SCh) and by 010 on the other.
Several additional aotions of depolarizera indeed are
oonsistent with the oonceptualization of the British investigators. For instanoe, anti-OhE agents whioh antagonize
d-tbo, are without effect upon SOh and CIO; some of them
aotually enhanoe or prolong their blookade (Karozmar. 1957;
Zaimis, 1959). As oan be expeoted, oompetitive blookers oan
antagonize the depolarizers; pretreatment with a small, subliminal dose of d-!bo prevents the action of SOh and CIO
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(of. for instance Karczmar and Fudema, 1957, and Xarczmar,
1961). In fact. antagonism of SOh and 010 by any other than
auraremimetio agents was, till reoently (of. below), never
demonstrated. Finally, depolarizing agents produce charaoteristio spastic para1ysis in the pigeon (Zaimis, 1952, 1953;
Hoppe, 1955), as do sometimes OhE inhibitors (0.0.).
It appeared subsequently that the status of the sooalled depolarization blookade oannot be quite so clearout. In a aeries of papers, Theslef! (1955a and b) showed
that in the frog at least, 0 10 and SOh blooked the neuromyal
transmission only after depolarization was over. Furthermore,
the effeots of methoxyambenonium (WIN 8078) in the oat and
in the dog (Karozmar and Boward, 1955; Karozmar, 1957 and 1961.
Lands, Karozmar, Howard and Arnold, 1955) upon 010 , SOh and
d-Tbo blockade oannot be reoonoiled with the original hypothesis of Za1mis (of. Karozmar, 1956, 1957 and 1961). Karozmar observed that methoxyambenonium antagonized the blookade
by both curaremimetios and depolarizers; as can be easily peroe1 ved from the toregoing, this is a unique property for
an agent active at the neuromyal junction.
Furthermore, the antagonism of SOh and 010 by methoxyambenonium takes a rather unusual form (Karozmar, 1956 and 1957 •
The usual effeot of SOh and 010 upon meol~ioal response of
the musole to indireot stimulation consists of a brief twitoh
increase followed by blockade. This blockade 1s converted
by methoxyambenonium into a continous increase of the twitch
response, which is not followed by a blookade COlO and SOh
"reversal"). Karozmar pointed out that if all the actions
of SOh and 010 depended on the1r depolarizing effeot, the
increase and prolongation of the twitch inorease due 010 and
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SOh by methoxyambenonium, should be followed by increased and
prolonged blockade. The action of methoxyambenonium, interesting because it bears upon original postulates of Zaimis with
regard to SOh and CIO ' has not been as yet explained; indeed,
it is difficult to conoeive how a compound which is a weak
anti-OhE (effective at doses probably incapable to inhibit, in
vivo, AChE; Karozmar, 1961) oan antagonize d-~bc; the coupling
of this action of methoxyambenonium with its antagonistic
actions upon SOh and CI0' is even more perplexing.
In view of these findings, Zaimis (1959) pointed out that
SOh and CIO act as pure depolarizers only in the cat fast (white)
muscles, such as tibialis or sartorius or in a "mixed" muscle
such as the gastrocnemius. In the case of the slow muscle of
the cat or in that of most musoles of certain species other than
the cat, SOh and CIa act as curaremimetic blocking agents, i.e.,
as competitors of ACh. Also, both Za1mis (o.c.) and Foldes
(1959) point out that, upon repeated administration, the action
of SCh and CIO can shift, even in the case of fast muscles,
from depolarizing to competitive. Finally, Blaber (1960) argued
that anti-CIO effects of methoxyaL;0c;nonium. was obtained in the
cat, at higher dose levels than ita anti-d-Tbc actions, and this
suggested that methoxyambenonium may antagonize CIO by preventinE
it from depolarizing. This, actually, may explain the antagonism between CIa and SCh on one hand and methoxyambenonium,
but not the "reversal".
Altogether, it is fair to state that, at present, the
mechanism of action of depolarizers, as well as that of methoxyambenonium, 1s controversial.
e. Flexibility of the cholinergic receptor and
conditioning of the neuromyal junction.
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It ap.Jeara from the foregoing that several mechanisms
may exist at the neuromyal junction with regard to antagonizing
blocking ~cti()n of d-fbc. Anti-OhE agents, fEA. Nal, methoxyambenoni~, and hydromethylammonium compounds may antagonize
d-Tbc in different ways. Moreover, these and still other
compounds may &odify the neuromyal transmission by means of
sev.ral different meohanisms. It should be added that Perry
(1953) speoulated on synaptio faoilitation, not based on ChEinhibition, without specifying the mechanism involved.
While all this points to the great flexibility of the
neuromyal junotion, another line of evidenoe indicates still
another type of control possible at that site. It was shown
sowe time ago (Koppanyi and Karozmar, 1953; Karczmar, 1955)
that whole organisms and oertain synapses (Wills, unpublished
data) may recover function relatively fast after large doses
of ChE i~~ibitors, before significant regeneration or reactivation ot ChE activity may take place (cf. also Barnes and
Duff, 1953; McNamara et al., 1954; Robinson et al., 1954).
Also at the neuromyal junction spontaneous recovery of function
ocours relat1vely rapidly atter lur~e doses of certain antiChE agents (Wills, unpublished data). While even in the case
of the SO-Called irreversible ChE inhibitors such as phosphonate
anti-ChE agents and war gases the reversal of inhibition may
occur in oertain nerve structUres faster than originally thought
(Koenig and Koelle, 1960), yet the above data indicate that the
whole organism or a 3peoific synapse may adapt to low levels of
ChE's and ooncomitant high levels of ACh.
Suoh an adaptation to ACh was observed direotly in the
case of autonomic ganglia (Krlvoy a~d Wills, 1956). At the
e.p., it was observed (Jatt, l~59) that ACh depolarization
I
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decreases in continuous presence of AOh. Further evaluation
of this problem at the neuromyal junction, and particularly
data on the adaptation of mechanioal response of indirectly
stimulated skeletal muscle to AOh are still laaking.
III. Purpose of the present researoh.
Analysis of the available pharmaoologio data pertinent
to the skeletal neuromyal transmission suggest, first of
all, that the mechanism of aotion of the so-called depolarizer
blocking agents is not fully understood. Specifically, reevaluation of the data of Thesleff (1955a and b) on the relation of depolarization to blockade of meohanical response
of the muscle is indicated. Jurthermore, the mechanism by
means of which methoxyambenonium antagonizes d-Tbc and reverses 0
and SOh block, is not understood at present. Also,
10
further study of newer, not fully understood, anti-d-Tbo
agents such as TEA and NaF is desirable, partioularly since
TEA and Nal were not investigated as antagonists of 010
blockade. The proposed research deals with the effects of
TEA, NaP and methoxyambenonium upon meohanioal responses of
the frog muscle to nerve stimUlationA~th the effects of TEA
and methoxyambenonium the e.p.p_ and muscle membrane; moreover,
the interaction of TEA and methoxyambenonium with 010 was
studied in terms of the mechanical and e.p. parameters of
transmission, and oompared with the interaction of these
oompounds with d-Tbo. All this should throw additional light
on the mechanisms of anti-d-fbo, anti-SOh and anti-010 aotion
of TEA, methoxyambenonium and Nal, and thus on new sites of
aotion withim the neuromyal transmission pathway.
Sinoe the results led to a concept of multipliCity of
sites and mechanisms of the neuromyal transmission, i.e., to
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the concept of the flexibility and multiple control system
as being characteristio for this transmission, it was thought
also important to study among the faotors of this flexibility,
also the adaptation and reoovery prooesses of the e.p.
~he exploration of these and still other possibilities
may throw a light on the important general prinoiple of the
"modulating" of the Cholinergio neuromyal transmission.
o. Methodg.
1. Colleotion of materials and data.
Dana pipi,ns, the form uBed in this investigation, were
obtained from a looal supplier. Winter frogs were generally
employed. Stook animals were kept in an appropriate aquarium,
and the experiments were run at a temperature optimal for the
frog nerve-muscle funotion, i.e. at 18-20°0; cooled organ
bath was used for this purpose. The data oonsisted of photographic records (obtained by means of the Polaroid and of Dumont Oscilloscope Cameras) and of polygraph traoings of musole
twitch. Sufficient number of experiments were carried out to
provide statistically dependable numerical values of the pertinent parameters.
2.

~eahnique8.

Experiments were generally performed on nerve-sartorius
muscle preparation of the winter frog. The preparation was
bathed in Ringer solution, in musole ohambers of various types,
the type depending on the experiment. Ringer solution oonsisted of 115.6 mM BaCL, 2 mM KCL, 1.8 roM CaC12' and 0.2 mM
NaHCO" the pH was 6.8. In experiments of long duration
oxygen was bubbled into the solution.
a. Reoording meohanical response of musole.

Isometric mechanical responses to indirect and direct
stimulation were recorded by means of a force transducer
coupled with Offner Type R Dynograph or with Grass Model 5
polygraph. ~he muscle was fixed at its pelvic end in the vertioal muscle bath and connected by means of its tendon with the
force transducer. When an indirect stimulus was employed,
the nerve was separated from the muscle and suspended from
platinum eleotrodes. ~he stimulator employed was from American
Electronic Laboratories (Model 1041). Generally, the single
st imulas had the streIl8th (in the case of supI'8.max1mal shocks)
of 1 to 5v, duration of 2 to 50 ms. Direct stimuli to the
muscle were also employed at the stimulus strength ofl to 8 v.
to ten
Trains of fiveAstimuli, one stimulus every 1 second, were employed. the interval between each train being 5 to 10 minutes.
There was a diminution of up to 20 per cent of twitch height in
the controls within 2 to 3 hours. Aocordingly, the twitoh obtained after an experimental prooedure was oompared to that recorded Simultaneously in the oontrol preparation. This was
particularly done to asoertain whether or not TEA or methoxyambenonium, used alone or in combination with ClOt increased the
musole twitoh above the control levels.
b. Measurements at the e.p. and at the muscle
membrane.
Essentially, the following parameters were studied per 8e
and with regard to the aotion of drugs ~nd drug oombination; 1)
the resting potential of the muscle fiber and of the e. p., 2)
the action potential of the muscle, 3) e.p. depolarization, 4)
the e.p.p. Intracellular and extracellular measurements were
employed.
In the former case capillary microelectrodea (Ling and
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Gerard type) were drawn by means of a micropipette puller,
(Industrial Science Assooiates Inc.) The micro-electrodes had
a tip diameter of less than 0.5 p_ They were filled with KCl
by boiling in 3 M KCl solution, and showed a resistance of less
than 20 megohms. In the measurement of the resting potential
and of the e. p. p., the muscle wa.s suspended in a. vertical J.luscle
bath, treated with a solution ot d-Tbc or 010 sufficient to
block transmission (generally 5 x 10-6 and 3 x lO-6M, respective~
ly), the solution discarded, and the e.p.p., induced by supramaximal volleys to the nerve, was tested. The microelectrode
was oonneoted to a cathode-follower input stage, and its outF4t
connected to two amplifiers and to cathode-ray tubes (!echtronix
Model 502). Resting potentials were observed by the cathoderay tube com4eoted to a d.o. amplifier. The same setup was
employed to reoord the miniature endplate potentials (m.e.p.p.'s •
Extraoellular eleotrodes were mainly used to measure the
persistent depolarization of the e.p_, shown by a difference in
surface potential between the nerve-free pelvic end of the sartorius and the e.p. region. The muscle-nerve preparation was
mounted, in a vertical perspex chamber, in the Ringer bath.
One Ag-AgCl eleotrode was plaoed on the pelvic end and the other
made contact with the fluid below the tibial end. The distribution of the surface pot ent 1a.l was mea.sured by means of an
arrangement allowing the movement of the muscle with respeot
to the surfaoe of the fluid which acted as a movable electrode
(Del Castillo et al., 1956a). All preparation with initial
potential of over 0.5 mv were discarded. It should be pointed
out at this time that the muscle has to be disseoted and prepared with utmost care to prevent injury.
In these experiments the location of the e.p. had to be
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TEA and methoxyambenonium, alone or in combination with C10'
on endplate sensitivity to ACh, each treatment was followed
by several washes and by a test of ACh depolarization to ascertain that the neuromyal junction returned to control conditions prior to the next procedure. Somewhat different sequences of exposures are described in the legends to various
figures and in the text.
D. Results.
I. Effects of pharmacologic Agents on meohanical response
of th! muscle.
1. Effects of methoxyambenon:i:um and of ChE inh.ibitors.
In the case of maximal or supramaximal stimulation of the
nerve, methoxyambenon1um did not increase the tvi toh amplitude
over a wide range of conoentrations (0.5 x 10-7 to 10-5 ; 15
experiments); stronger conoentration (10-~ and higher; 14
experiments) caused slowly deVeloping blockade which became
complete within 30 to 50 minutes when the weaker ooncentration
was used and faster with stronger concentrations (fig. 1).
Also in the cat methoxyambenonium did not increase the twitch
of indirectly stimulated muscle (Karczmar, 1957). It may have
been expected that, as in the cat, so also in the frog, ineffectiveness of methoxyambenonium could be contrasted with
the well-known effectiveness of ChE inhibitors in increasing
the twitch height. ~his proved not to be the case, and the
potent anti-ChE agents, such as eserine, ambenon1um and neostigmine, proved incapable over a wide range concentration to
potentiate the twitch. With higher concentrations blockade
could be observed; weak blockade occurred, for inatance, in the
case of 5 x 10-6M concentration of ambenonium (4 experiments)
and more complete blockade in that of 5 x 10-5M concentration
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(3 experiments).
While generally not desoribed in the literature, this
lack of effeot of anti-ehE agents upon the twitoh of indirectly
stimulated frog musole is known (Koketsu, personal oommunioatio~).
It should be remembered that, in the mammal, it is difficult
to potentiate by means of anti-ObE agents the response to
preganglionic stimulation (McIsaaohs and Koelle, 1959), unless
the preganglionic nerve trunk is longitudinally split and a
thin strand used for the stimulation, or unless submaximal
stimulation is used.
It was aooordingly attempted to test the effeot of drugs
upon the twitoh amplitude in the frog:after technioally diffioult splitting of the motor nerve, or by using submaximal
stimuli. In these oonditions, methoxyambenonium (1-5 x 10-~)
inoreased the twitoh height in 12 out of 22 experiments from
20 to 40 peroent.
~he augmentation lasted tor relatively short time periods
(3 to 10 minutes); ambenonium and neostigmine proved more
effeotive, inoreasing the twitoh from 30 to 50 peroent; also,
the inorease lasted longer (5 to 15 minutes; 5 experiments per
oompound).
1inally, TEA (0.; to 1 x 10- 3.) did not augment muscle
twitoh whether supra- or sub-maximally stimulated (15 experiments); in higher conoentrations (5 experiments) TEA produoed
initial inorease of musole twitch amplitude; this was rapidly
followed by blookade. It should be pointed out that, in the
past, tEA was found to inorease the twitch of indireotly stimulated frog sartorius (Ing and Wright, 1933). This was also
demonstrated in the kitten but not in the adult cat (Sullivan
and Kensler, 1950).
It should be stated that neither TEA (5 x 10-5 to
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5 x 10-3M) nor metho~ambenonium (10-7 to lO-4M) had any signifioant effeot, within a wide range of conoentrations, upon the
twitoh of the direotly stimulated muscle (15 experiments per
oompound).
2. Interaction between ClOt methoxyambenonium and
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010 (3 x 10-6 to 1.5 x lO-4M), produoed, as is well known,
blookade of indireotly, supra-maximally stimulated frog musole
(22 experiments). Interaotion between C10 and ~EA or methoxyambenonium was studied using eupramaximal stimulation of either
the divided or the intaot nerve, or em~loying eubmaximal stimulation. With intaot nerve and supramaximal stimulation,
methoxyambenonium, used at the point of almost oomplete 010
blookade, produoed partial restoration of transmission only
rarely (fig. 2; 3 out of 15 experiments). However, more oonsistant partial antagonism between C10 and methoxyambenonium
(3 x 10-6 to 1.5 x 10-4M) ooourred whenever divided nerve or
submaximal stimulation was used (12 experiments, fig. 3). TEA
(3 x 10-4 to 10-3M) was more effeotive against 010 than methoxyambenonium (10 oases); it produoed regularly marked restoration
of transmission whioh was blocked by 010' whether sub-maximal
or supra-maximal stimulation was used (10 experiments; figs. 4
and 5). Particularly in the oases of sub maximal stimulation,
the musole twitoh depressed by 010 was augmented by fEA to a
height above that of oontrols obtained prior to 010 (6 experiments; fig. 5). The effect of TEA was espeoially pronounoed
in the case of the first few responses; the twitoh amplitude
subsequently deoreased (fig. 4).
Several other agents were tried as possible 010 antagoniste.
Hal (5 x 10-3M to 5 x 10-5M), a "sensitizer" of the e.p. (of.
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Introduction, and Koketsu and Gerard, 1956), had negligible
effect on C10 blockade when supramaximal stimulation was
used (5 experiments); it exhibited antagonistio aotion when
sub maximal stimulation was used (7 experiments). The restoration of the twitoh height amounts to about 30 percent.
Anti-Chi agents, ambenonium (10- 7 to 10-5H), neostigmine
(10- 6 to 5 x 10-5H), and eserine (0.5 to 1.0 x 10-5M) had
no effect upon 010 blookade of maximally stimulated nervemusole preparation (15 experiments per oompound); in fact,
as sometimes in the mammal (Karczmar, 1957 and 1961), these
oompounds increased the blookade under these oiroumstanoes
(fig, 6). When submaximal stimulation was used, partial
(about 20 percent). temporary (3 to 5' minutes) restoration
of transmission was sometimes observed. This was most
notioeable in the case of neostigmine. An interesting result
was notioed when neostigmine in relatively weak (10- 7 to
10- 6.) ooncentrations was employed simultaneously with C10 '
(8 experiments; fig. 7). Under these oiroumstanoes, neostigmine delayed the onset of 010 blockade. This effeat was
not observed when eserine (9 experiments) was applied simul.neously with ClOt It is of interest that in a few experiments, a oombination of eserine (5 x lO-~) and of
methoxyambenonium (5 x 10-6M) oaused partial restoration of
transmission blooked by C10 ' even when supramaximal indireot
stimulation was employed (in 7 out of 8 experiments; fig. B).
Other than eserine anti-OhE agents were not employed in oombination with methD~yambenonium.
It appears from this section that Til, methoxyambenonium
and Nal, are, in this sequenoe, most effeotive antagonists
of 010 blo ckade, ant i-OhE agents being ineffeoti ve in this
respect.
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3. Interaction between d-fbc, TEA and methoxyambenonium.
Generally, 3 to 5 x 10-6X concentration of d-Tbc was
used to cause neuromyal b~~ckade of the indirectly stimulated
frog nerve-muscle preJ;aration; used at this strength. d-~bc
generally caused a 70-90 percent reduction of the twitch.
Methoxyambenonium (1.0-2.0 x 10-6M; 12 cases) caused, within
a few minutes, restoration of transmission lasting from 5 to
10 minutes (fig. 9); however, blockade returned subsequently.
Faster deblocking as well as more rapid return or intensification of original d-Tbc blockade was:noticed with stronger
concentrations of methoxyambenonium.
fEl had similar, biphasic effect upon curarized muscle.
Weaker concentrations (3 to 5 x 10-4M; 15 experiments) produced
restoration of transmission without subsequent blockade (fig.
10).Asin the case of the effects of TEl upon C10-blocked
transmission, the action of TEA was particularly pronounced
C().$e of the
in theAfirst few responses. With higher concentration of TEl,
the mechanical responses were initially augmented and gradually depressed. fhis confirms the earlier data of Koketsu (1958).
4. Effects of ACh in various experimental conditions,
on the response of the indirectly stimulated
muscle.
~he most conspicuous action of effective concentration
of ACh was its blocking effect upon transmission. This was
noticed with a relatively wide range of ACh concentrations.
Yet, it became apparent that ~itch increase may be obtained
with this agent, since frequently, after the depressant action
of AOh was recorded and the preparation washed with Ringer,
the twitch amplitude was increased by 20 to 40 percent,
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presumably beoause traoes of ACh remained on the reoeptor
(12 .xperimentsj fig. 11 and 12). It was not easy to find
the concentration of ACh capable of increasing the twitch
amplitude without recurring to washing; however, several
experiments (18 out of 35) could be carried out in whioh
ACh (5 to 7 x 10-6M) caused inorease of twitoh amplitude
(f~. 11).
In this respeot, ACh resembled C10 exoept that
facilitatory effect of CIO oould be more easily demonstrated
than that of ACh (cf. belOW p.3S).
Negligible reoovery was generally notioed with the
ooncentrations of ACh oapable of pro~ucing marked neuromyal
depression (10-5 to 10-4M). fhis was true even when experiments were oarried out for 3 or 5 hours. It should be, how- .
ever, pointed out that oontrols also exhibit reduction of
the musole twitoh over oomparable time periods (of. Methods),
and that therefore some reoovery may have set in but was
masked by deterioration of the preparation. fhis effeot
of strong oonoentrations of ACh resembled that of CIO, whioh
was also found essentially irreversible (of. below p~).
However, in the oase of weaker oonoentration of ACh
(5 x 10-6 to 10-5M), which produoed relatively small, less
than 50 peroent depression of transmission, reoovery oould
be observed repeatedly. It frequently ooourred within 5
minutes of the onset of blockade (figs. 12 and 13). Similar
results were reoently reported by Smith (1960). It is of
interest that in the presenoe of neostigmine spontaneous
reoovery would also ooour (figs. 13 and 14; 9 experiments
out of 15), when weak concentrations of ACh were employed.
It should be pointed out that, in the !a !!!2 experiments
in whioh AOh was administered i.a. or i.v. to oats or dogs to
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produce neuromyal actions, the ACh could be disposed of by
combined action of ChEfs, tissue diffusion, and removal by
the blood stream, but in the !a vitro experiments ACh remains
in touch with the muscle throughout the whole experiment.
Thus, the recovery was spontaneous and oocurred in the continuous presence of ACh. It could be stated that the recovery constituted a case of adaptation to depressant levels
of ACh.
Another instance of adaptation to ACh was demonstrated
in experiments conducted somewhat differently from the previous ones. In these experiments, the preparation was "conditioned" to increasingly higher a~d higher concentrations of
ACh; it could be shown that, after the "conditioning", even
a strong concentration of ACh (5 x 10-5M), capable of marked
blockade of an "unconditioned" preparation, was ineffective
(11 experiments). In other experiments of this type, concentrations of ACh, effective in control experiments, were
found ineffective in "conditioned" muscles (12 experiments;
figs. 15 and 16). This, then, is a case of ACh tachyphylaxis,
which was so far described only by Smith (1960). It should
be pointed out, however, that conditioning could occur only
with concentrations of ACh capable of slight, 20 to 25 percent,
blockade (fig. 16). In other words, ACh tachyphylaxis was
never pronounoed.
As already stated (cf. section 2 above). anti-ChE
agents frequently synergized with CIO in the production of
transmission blockade. Similarly, ACh generally synergized
with neostigmine and eserine in the production of the blockade.
In the presence of neostigmine (10- 6 to 10-7M) or of eserine
(10- 5 to 10-4M), it sufficed to employ 10- 7 to 5 x 10-~

concentration of ACh to produoe 30 to 50 percent blockade of
transmission. when used alone, ACh had to be used in conoentrations of 5 x lO-5X or higher to produoed similar degree
of blookade (of. supra). As desoribed before, weaker concentrations of ACh and of neostigmine did not produce blookade
(fig. 13).
Another agent which produced blockade SYl:ergistically
with ACh was methoxyambenonium. As already described, used
alone, methoxyambenonium never produced any blockade at
concentration lower than 1.5 x lO-5X (of. Section 1 above).
while ACh was never markedly depressant at less than 10-~.
Used jOintly, these agents were markedly blooking at concentrations of 10-ax of AOh and 10-7M o£ methoxyambenonium (6
experiments). The reoovery from suoh blockade was slight
within the usual experimental duration (2 hrs.).
5. Effeots of C10 upon the response of the indirectly stimulated muscle.
010 effect upon neuromyal junotion differed in several
respeots from that of ACh. In the first plaoe, it was relatively easy to obtain inorease of the twitoh response with
ooncentrations ranging from 10- 6 to 10-5M• In the case of
weak ooncentrations of C10' twitch increase lasted for the
whole experimental period (up to two hours; 12 oases; fig. 17).
This effect of 010 can be contrasted with that of ACh, in
whioh case twitch inorease oould not be easily demonstrated,
and when obtained, it was only ~emporary. In the oase of
stronger concentrations of CIO ' the initial twitch increase
subsided and progressive blookade took plaoe, the rate of the
ocourrence of the blockade depending upon conoentration. The
blockade was complete in 30 minutes in the case of 5 x 10-5K

solution of 010. !he following finding was also of interest.
In the control preparation, as well as after the twitch
magnitude was increased by a weak conoentration of C10 ' a
typioal "treppe" effect was observed in most of the cases (figs.
17 and 18).
As already stated, spontaneous reoovery was not notioed
in the oase of either faoilitating or blocking conoentrations
of 010. Iven in the case of concentrations of 5 x 10- 6 to
6 x 10-5• of 010' produoing some facilitation first and relatively slight blockade within 30 or 40 minutes, no reoovery
but rather progressive blockade, terminating in complete block
within 1 to 2 hrs., was noticed. This constitutes then another
difference between C and ACh.
10
'inally, adaptation phenomena were never notioed with 010.
In several experiments, 010 solutions (10- 6 to 5 x 10-~)
causing some twitoh increase at first and some blockade later,
were replaced, when blockade ensued, by somewhat stronger
solutions (6 x 10-5 to 10-5.); in all oases increased blookade
was observed. When the preparation was washed in Ringer
between the two applications of C10 ' the block increased when
the preparation was placed in the second 010 solution (fig. 19).
Bven when stronger solution was substituted for the weaker
solution at the time when the latter produced twitoh inorease
only, blockade oocurred. This, non-adaptive behavior of 010'
again differed from the taohyphylaxis effect notioed in the
case of ACh.
II. )ffects of pharmacologic agents at the endplate.
1. Effects of methoxyambenonium, ~EA and 010 on
muscle membrane and at the endplate.
It was determined, first of all. that neither methoxyam-
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benonium (1.5 x 10-7 to 1.5 x 10-4X), nor CIO (3 x 10- 6 to
1.5 x 10-4M) nor finally !EA (10- 3 to lO-5M) had any effect
on both the resting and action potenttal of single fibers.
~EA and methoxyambenonium resembled each other in that they
did not have any direct effect upon the resting potential of
the e.p. in oonoentrations ot 1.5 x 10- 7 to 1.5 x lO-6:M. ~hus,
they are not depolarlzing agents; also, they presumably have
no direot myogenic aation, as already suggested by the laok
of their aotion upon the directly stimulated frog muscle (cf.
supra, Seotion 1-1).
Methoxyambenonium showed one lnt~resting activity at the
e.p. in whioh it differed from ~EA. At a relatively low
concentration of 5 x lO-~, methoxyambenonium increased the
amplitude (by 0.5 : 0.1 mv), but not the frequency of m.e.p.
p.'s (fig. 20; 250 ~ 18/30 minutes; 7 experiments) while TEA
did not seem to affect the m.e.p.p.'s. It appeared that, at
optimal conoentrations (10- 6 to 5 x 10-5M), eserine did not
produce as much effect upon m.e.p.p.'s as methoxyambenonium
(fig. 20). Control m.e.p.p.'s showed an average of 0.3 to
+
0.1 my, while after eserine they averaged 0.4 - 0.1 mv.
010 had, as it is well known, a depolarizing action
at the e.p.t whioh was obtained with ooncentrations of 10-7
to 1.5 x 10-4M. This action of CIO was almost entirely confin d
to the e.p.
2. Effects of TEA and methoxyambenonium on the e.p.p
E.p.p. was obtained by blocking the transmission either
by 010 (generally 5 x 10-6M) or by d-Tbc (generally 3 to 5 10-

M).
With regard to curarized preparatio~ the a.p.p. action
of methoxyambenon1um was, interestingly enough, very different
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from that of TEA. In briet. methoxyambenonium markedly augmented the e.p.p. (fig. 21). Measured extracellularly, the
e.p.p. varied between 2 and 4 my; measured intracellularly,
between 10 and 30 mY. The augmentation amounted to 1.2 ~ 0.3
mv and 10 .!. 0.4 mv, measured extra- and intra-cellularly,
respectively. Yet, even when concentrations of methoxyambenoni
reversed the aotion ot d-tbo (1.5 x lO-4M) and the e.p.p. was
increased past the oritioal depolarization potential whioh produoed a spike, repetitive tiring was never notioed. !he effect
was prolonged and consistent. All •• p.p.'s of any particular
train of stimuli were affeoted similarly. still higher concentrations tended to lower the e.p.p.t s • Pinally, methoxyambenonium did not change the pattern and shape ot the e.p.p.;
particularly, the falling phase of the e.p.p. was not prolonged
(tig. 21). Per instanoe. in the case of 1.5 x lO-6r.t methoxyambenonium solutions the time value of the decline ot the e.p.p.
to half its peak value was 1.8 ~ 0.4 ms, and thus was quite
similar to that of the oontrol e.p.p. (1.7 ~ 0.4 ma), although
the latter was half the height of the tormer. fhus, methoxyambenonium oaused augmentation but no prolongation ot the
e.p.p. ot curarized preparation.
While TEA also inoreased the e.p.p. ot the curarized
preparation, this augmentation differed from that produoed by
methoxyambenonium. !El, 2 x 10-4M to about 5 x 10-4M (threshold conoentrations and higher), produoed augmentation proportional to TEl concentration, combined with prolongation
ot the falling phase of the e.p.p. (duration ot decline to half
the peak value 2.1 1 0.5 ms).
In taot, the e.p.p. pattern
was ohanged generally: the latenoy and the rising phase were a,Iso
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prolonged, although the falling phase and the duration of the
e.p.p. were mO$t affected. It was also noticed that the
effect of !J4 was most oonspiouous in the case of the first
e.p.p.' s of .eacn train of stimuli; repeated stimulation of
the nerve bro~ht about e.p.p.'s of oontrol size and shape.
In the case of these earlier e.p.p.'s, TEA (5 x 10-~) produced augm~tation amounting to 1.5 ± 0.3 mv and 14 ~ 0.4 mv,
measured extra- and intra-cellularly, respectively.
Higher (10- 3 to 3 x 10-3M) concentration of fEA caused
manifold e.p.p. ohanges. Repetitive firing and considerable
augmentation and prolongation of the first e.p.p.'s of eaoh
train of stimuli were notioed; depression of subsequent a.p.p.'
a of eaoh train of stimuli tollowed. 5 x lO-3M concentrations
and higher led to immediate decrease of the e.p.p.'s in
absence of repetitive tiring. Some ot theae observations
were already reported by Koketsu (1958).
It was of particular interest to record the changes
produced by methoxyambenonium and Til upon the e.p.p.'s obtained when the transmission was blocked by 010. This e.p.p.
was generally smaller than the e.p.p_ obtained in curarized
preparations (fig. 22 and 23). The rather surprising finding
waa that the efteot ot methoxyambenonium and of TEA was
essentially similar or even identical with that produced by
these agents in the oase ot the e.p_p.'s of curarized preparations. Again, TEA increased and augmented the e.p.p.,
when used in lower oonoentrations (3 x 10-4 to 5 x 10-3M);
used in these conoentrations, TEA inoreased the e.p.p. by
1.4 ~ 0.4 mv (extraoellular recording). In higher conoentrations (lO-4M) TEA. actually produoed repetitive firing
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(fig. 22). As before, the restoration of the e.p.p. was
Iarticularly noticeable after the first nerve stimulation;
thereafter, subsequent stimuli produced smaller e.p.p.'s.
Higher concentration of TEA (5 x 10- 4 to 10-3M) decreased the
e.p.p. due to CIO' just as it decreased the e.p.p. of curarized
preparations.
As in the case of e.p.p.'s of curarized preparations,
the effects of methoxyambenonium upon e.p.p.'s obtained in
the presence of CIO resembled those of TEA in one respect and
differed in several others. Methoxyambenonium (5 x 10- 5 to
5 x 10 -6 M) augmented but did not prolong the e.p.p. (fig. 23).
The effect was consistant, i.e., e. p. p:. 's obtained by first
stimuli of each train were not augmented more than those due
to subsequent stimuli. However, neither repetitive firing nor
prolongation of the e.p.p.'s was produced by methoxyambenonium
within this range of concentrations.
It is well known that anti-ChE agents produce an increase
of e.p.p.'s of curarized preparations, and, in the case of
higher concentrations, spiking and repetitive firing (cf. for
instance, Nastuk and Alexander, 1954); one of the most conspicuous e.p.p. effects of anti-ChE agents was the prolongation
of the falling phase of the e.p.p. These data could be reproduced at present. In the case of eserine, the duration
of the decline to half the peak value was 2.5 ! 0.5 ms, as
against 1.7 ±. 0.4 ms duration in the control experiments (fig.
23). On the other hand, anti-ChE agents (for instance eserine,
10- 6 to 10-5M) did not increase the e.p.p. when the transmission was blocked by C10 ; the only effect notioed with these
and higher ooncentrations of eserine was a decrease of the
e.p.p. amplitude (fig. 23; 8 experiments).
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3. Endplate action of 010 (3 x 10- 6 to 1.5 x 10-~)

was measured in these experiments simultaneously
with the reoording of the musole twitoh.
these measurements entirely oonfirmed the conolusions of
~hesleff (1955a and b) that 010 depolarization in the frog is
temporary, and that its time course is different from tllat of
its transmission blookade.
When measured with the external electrodes, depending upon
010 ooncentrations,maximum depolarization varied between 2 and
7 my, reaohed its peak within 1 to 15 minutes, deoreased subsequently and oompletely subsided within 15 to 50 minutes
(fig. 24). At the same time the blookade of meohanioal muscle
response to indirect stimulation was first noticed well after
depolarization; as the muscle repolarizedthe maximal blookade
ot transmission ooourred well afte~ oomplete return of e. p.
membrane to nor.mal polarization (fig. 24).
4. Analysis ot 010 blookade of neuromyal transmissio~,
and of its antagonism by ~EA and by methoxyambenonium.
Since the above data indioate that 010 depolarization
oannot account for transmission blockade, the experiments of
Theslef! (0.0.) indicating that this blookade is due to ACh
"desensitization- of the e.p. were repeated and expanded. 010
in all ooncentrations oapable of initial depolarization and
subsequent blookade (10- 6 to lO-4M) decreased AOh depolarization
at the e.p. ~e pattern of AOh depolariZation was, essentially,
not affected; in the presenoe of 010' the time course of AOh
depolarization was parallel to that due to AOh alone (15 experiments; figs. 25 and 26). Sinoe this suggests competition
between 010 and AOh, it may be predioted that ~EA and methoxy-
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ambenonium, antagonists of CIO transmission blockade, would
sensitize the e.p. to ACh. Yet, this did not prove to be the
case with TEA. Actually, the effect of TEA upon ACh depolarization was very similar to that of CIO itself (12 experiments;
fig. 25); this confirms the data of Koketsu (1958).
On the other hand, methoxyambenonium (5 x 10- 6 to 10-5M)
markedly increased ACh depolarization by 2.1 ~ 0.5 mv (external electrode measurement) in the case of stronger concentrations. An interesting feature of this sensitization was,
that again, a family of parallel curves was obtained; ACh depolarization in presence of methoxyamb~nonium was increased
over, and parallel to, that caused by ACh alone (11 experiments;
fig. 27). In other words, methoxyambenonium increased but did
not prolong ACh depolarization. In this, the methoxyambenonium
effect differed markedly from the well-known action of antiehE agents, which as well as augmenting it prolongs ACh depolarization (13 experiments; fig. 28). Finally, at relatively high conoentrations (10-4M), methoxyambenonium depressed
ACh depolarization (fig. 27), i.e., it desensitized the e.p.
to ACh.
A reference should be made at this time to the blookade
of neuromyal transmission recorded when a combination Jf very
weak concentrations of methoxyambenonium (lO-7M) and of ACh
(lO-8.M; cf. p. 36) were tested. It could be shown at present
that, employed in these concentrations, neither agent nor
their combination produoed measurable depolarization. On the
other hand, when the block was produced by combining ACh with
anti-ChE agents such as eserine and neostigmine (of. p. 36,
p.: 32), the effective oonoentrations (10- 5 to lO-~) of ACh
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could produce some depolarization, which was markedly intensified by the anti-ChE agents at concentrations employed (14
experiments; fig. 28).
It appears that whlle sensitization of the e.p. to ACh
may be underlying the antagonism between methoxyambenonium
and ClOt TEA must antagonize CIO by its e.p.p. action, since it
actually desensitizes the depolarization of ACh. This could
be substantiated by additional lines of evidence.
First, it could be shown that CIO synergizes with d-Tbc.
When CIO (10- 5 to 10-6X) was added to a curarized preparation,
the e.p. was first augmented; then, sirice the resting potential
of the e.p. was raised by the depolarizing action of CIO ' the
e.p.p. was decreased. Finally, when the CIO depolarization
subsided, the base-line returned to normal and the e.p.p. was
markedly reduced. With higher concentrations of CIO and d-Tbc
(at concentrations of both agents of 10-5M), e.p.p.'s were
completely blocked. TEA could increase the height and the
duration of e.p.p.'s obtained by combined use of C and d-Tbc,
IO
producing repetitive firing with 10-4X concentrations. As in
the case of e.p.p.t s produced in the presence of C
or d-Tbc
10
alone, methoxyambenonium again resembled TEA in antagonizing
e.p.p.'s obtained in the presence of C10-d-Tbc combinations;
again, it neither prolonged s.p_p.ts nor caused rep6titive
firing.
In another experimental series, AOh sensitivity was decreased by C ' and the effects of TEA and of methoxyambenonium
IO
upon desensitized e.p. measured. TEA (0.1 - 0.5 x lO-4M) could
never restore the e.p. sensitivity (fig. 29). Actually, at
higher concentrations, TEA additionally reduced ACh depolarization after its partial reduction by 010 • This could be
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expeoted on the basis o~ the blooking actions o~ TEA upon AOh
depolarization (vide supra). To the oontrary, methoxyambenonim
in conoentrations o~ 5 x 10- 5 to 5 x 10-~ could at least
partially restore AOh depolarization reduced by 010 (15 experiments; fig. 26). The average inorease was 1 ± 0.' mv (extraoellular recording). As in the oase o~ the depolarization produoed by AOh in the absenoe o~ CIO ' methoxyambenonium augmented, but did not prolong ACh depolarization obtained in the
presenoe of 010 • Finally, stronger oonoentrations of methoxyambe~onium additionally decreased AOh depolarization, already
reduced by 0 • In other words, methoxyambenonium exhibited
10
in this, as in cany other experiments, biphasic aotion.
5. AOh depolarization and neuromyal blockade.
The time course of AOh depolarization was compared in
these experiments to that of AOh blookade of neuromyal transmission. At concentrations of 5 x 10- 6 to 5 x 10-5M of AOh,
depolariza~ion measured with external electrodes reached within
1 to 2 minutes a peak of from 3 to 8 mv.
Thereupon, in spite of the oontinued presence of AOh, or
application o~ a fresn solution, the depolarization deoreased
and subsided in ~rom 10 to 15 minutes, depending on AOh concentration (~ig. 30 to 32). The response of the musole to
indireot stimulation, on the other hand, followed a dif~erent
time oourse, sinoe it was first notioed at a oJnsiderable time
after the peak o~ depolarization was reached, and sinoe it
reaohed its maximum a considerable time a~ter the depolarizatio
was over (more than 100 experiments; ~ig. 30). Recovery ~rom
the blookade of transmission ensued later. In other words, the
e.p. potential exhibits two funotionally very dif~erent phases
of AOh action; the first phase immediately a~ter the reversal
o~ AOh depolarization, when AOh blocked muscle response to

indirect stimulation; and the second phase when reoovery from
transmission blockade oOuld be observed.
During both these phases the e.p. was resistant to depolarization aotion. In the oontinous presence of ACh,
eserine and neostigmine oould not restore depolarization (15
experiments; fig. 29); methoxyambenonium was also ineffective
under theae conditions. However, increasing the ACh ooncentration produced $ome slight depolarization, even when the
conoentrations of ACh in question were oapable, prior to first
administration of ACh, of producing maximal (8 mv) depolarization (fig. '2). Even half-an-hour after the cessation of ACh
depolarization, ACh sensitivity of ;the e.p. did not return to
normal, i.e., strong conoentrations of ACh could produce, at
this time, only small depolarizations. Pretreatment with
eeerine prior to adding either high or low concentrations of
ACh did not increase the eftect of the latter; in fact,
eserine seemed to decrease the effeotiveness of ACh in depolarizing the desensitized e.p. On the other hand, methoxyambenonium at 10-6 to lO-7M produoed, combined with 10-9M ACh,
the highest depolarization of which the desensitized e.p.
seemed to be capable, although even this depolarization (3-5
my, 12 experiments; fig. 32) was significantly short of the
maximal depolarization whioh ACh could produoe in a fresh e.p.
The effectiveness of methoxyambenonium was not increased by
employing stronger concentrations of this compound with AOh
in various concentrations (10- 5 to 10-~).
E. Di89u8,1on.
Two major problems will be considered in this discussion.
One problem concerns the mechanism of 010 blookade, and that
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of the interaotion between 010 and various pharmaoological
agents, particularly as it refleots on the mechanisn. of the
antagonism of CIO by TEA and methoxyambenonium. The other
problem 1s related to the effects of ACh at the e.p. and upon
the neuro~al transmission, and it deals also with the comparison of the neuromyal effects of ACh and C10.
1. Mechanism of the blockad. by CIO of froS
neuromyal transmission.
a. Blocking action of CIO at the neuromyal
junction.
It seems likely that, as already proposed by Thesleff
(1955a and b), 010 blockade of the neuromyal transmission in
the frog is not due to depolarization. He cited several lines
of evidence indioating just this; perhaps the strongest one
being the differenoe between the time course of 010 neuromyal
blockade and that of 010 e.p. depolarization. A.lso, simultaneously with produoing the neuromyal blockade, 010 desensitized
the e.p. to AOh, and the pertinent experiments suggested that
these two oompounds may compete for the reoeptor site. All
these results could be confirmed at present. Moreover, in some
of the experiments described herein, the a.p.p.'s could be
deoreased or even oompletely flattened by either excessive oonoentrations of d-fbc and 010' or by 0lO-d-Tbc combinations~
these experiments suggest that d-fbc and 010 synergize with
each other, and have a similar mechanism of action. Finally,
the results obtained at present demonstrate the antagonistic
action of methoxyambenonium and TEA upon 010 blockade, and show
that this antagonism is similar to that which methoxyambenonium
and TEA exert with regard to d-Tbc. It is diffioult to explain
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these antagonisms without assuming that C10 blockade is due
to desensitization of the e.p. to ACh, although even then the
full understanding of these phenomena is not easy, as will be
shown below.
b. Anti-C10 effects of TEA, methoxyambenonium
and NaF.
It should be stressed that these agents not only antagon1~ed
C ' but also d-Tbo blockade. If C10 blocks by ACh desensiti2~
10
ation or, possibly, by competing with ACh, and if this block j~,
therefore, similar to that produced by d-Tbc, antagonism of bc~h
C10 and d-Tbc by one and the same compound should be expeoted.
While this-concept would explain the "double" antagonism of dTbc and ClOt exhibited by TEA, methoxyamhenonium and NaF, it
offers also difficulties. One would, for instanoe, expect, tlat
CIO,as a desensitizer of the e.p. or as a competitor of ACh,
should be antagonized by anti-ChE agents; yet, as in the mammal
(Zaimis, 1959; Karozmar, 1957 and 1961), so also in the frog
CIO blockade is, if anything, deepened by ChE inhibitors suoh as
ambenonium, eserine and neostigmine. Also, anti-ChE agents d4press the e.p.p. obtained in the presence of C10 • It should 1:e
pointed out that the anti-ChE compounds employed are very potEnt
inhibitors of AChE and thus should easily produce ACh accumulation capable of depolarizing even a desensitized e.p., whicI
is one of the possible mechanisms underlying the antagonism 0
neuromyal blockade (Riker, 1953). In view of the ineffectiveness of anti-ChE agents, it may be suggested that the antagonism depends rather upon displacement of the blocker by the
antagonist, as proposed by Riker (o.c.), and that the anti-Ch
agents in question cannot displace CIO because they do not ex
hibit sufficient affinity to the neuromyal junction. However
it is not likely that lack of antagonism of CIO ' partioularly by aD
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benonium, is due to the lack of affinity to or activity of
this compound at the e.p. Indeed, ambenonium produces direct
muscle effect (Karozmar, 1957; Land et al., 1955) and actions
upon neuromyal transmission at the levels of less than a
microgram, and thus is a much more potent substance than C .
IO
Even in the frog, where the desensitizing mechanism of
C blockade, amply documented here as well as by Thesleff
IO
(1955a and b), may explain why certain agents can antagonize
both C and d-Tbc, the behavior of the CIO blockade with reIO
gard to anti-ChE presents difficulties. The situation is even
more obscure in the mammals (cats and, dogs). In these species,
the ~esensitizing character of CIO blockade is less well document,d, and the evidence is mainly indirect. Foldes and his
associates (cf. for instance, Foldes, 1959) and Zaimis (1959)
presented data indicating that upon repeated C administraIO
tion C blockade in slow and in fast muscles exhibits aspects
IO
of competitive blockade, since it is antagonized by anti-ChE
agents. Actually, methoxyambenonium antagonizes and "reverses
01 0 or SOh upon its very first administration to a fast muscle
of the cat. This obviously suggests that also in the mammals,
C and SCh action and block cannot be purely depolarizing in
IO
nature, even in th~ early phases of their action. If it were
so, methoxyambenonium which potentiates the excitatory action
of CIO and SCh, should subsequently produce increased blockade
rather than cause "reversal", i.e. conversion of SCh and CIO
blockade into a prolonged increase of the twitch response.
It should be stressed that recently Blaber (1960) argued
that a similar conclusion (cf. Karczmar 1956, 1957 and 1961)
is not warranted, and attempted to expl~in the anti-C IO
effects of methoxyambenonium in terms of the original hypothes s

47.
of Zaimis (1953). He pointed out that anti-C IO effects of
methoxyambenonium were obtained upon i.a. administration in the
oat at lower dose levels tr~n its anti-d-Tbc actions. It was
-_ ..
also suggested that higher doses of methoxyambenonium may antagonize C by desensitizing the endplate to depolarization.
10
However, in the case of the i.v. route in the cat (Karczmar,
1957) as well as in that of the frog nerve-muscle preparation,
doses of methoxyambenonium capable of antagonizing CIO and
d-Tbc are comparable or identical. Furthermore, methoxyambenonium can antagonize CIO only at concentrations which are
considerably below those producing AOh desenSitization and
concomitant blockade of neuromyal tranSmission (Karczmar, 1957).
Also, if depolarization were indeed the mechanism underlying
010 blockade, facilitator,y effects of methoxyambenonium confirmed by Blaber (o.c.) should lead to synergism between C
10
and methoxyambenonium, whioh was not the case either in the
cat or in the frog.
Even if we assume that action of methoxyambenonium upon
010 block, in the oat and frog, may depend on the desensitising charaoter of 010 and SOh block, two problems still remain:
the explanation of the "reversal" of 010 and SOh action by
methoxyambenonium, and of the laok of antagonism of SCh and
010 blook by anti-OhE agents. These two problems will be
analyzed further after a discussion of the action of the antagonists of CIO blook, TEA, NaF, and methoxyambenoni~~. Indeed,
it may well be that the answer to these problems lies in the
nature of this aotion.
o. Meohanism of action of methoxyambenonium, NaP
and TEA.
The diffioulty in explaining the action of methoxyam-
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benonium, HaF, and TEA, is that while depolarizers, curaremimetics, anti-ChE agents or hydroxymethylammonium compounds
show some of the characteristics of these three agents, yet
the combination of properties exhibited by these three compounds is unusual (Table 1). TEA augments e.p.p. but is not
an anti-ChE agent (Koketsu, 1958), or a depolarizer. In fact,
TEA blocks ACh depolarization (Koketsu, 1958), and it increases
ACh desensitization produced by CIO. Also, while TEA produces
repetitive firing at the e.p., it does so when employed in high
concentrations, not required for its anti-curare effects and
for the augmentation of the e.p.p. Thus, TEA is not an antid-Tbc agent by vi~tue of the mechanism: proposed by Riker et ale
(o.c.). Similarly, methoxyambenonium augments e.p.p., increases the m.e.p.p.'s and sensitizes the e.p. to ACh; yet it
is a weak anti-ChE (Lands et al., 1955; Karczmar 1957) and at
concentrations (10- 6 to 10-7M) capable of actions at the neuromyal junction it does not inhibit AChE (Arnold et ale 1954). 1)
Also, methoxyambenonium produoes neither depolarization nor
repetitive firing. NaF also causes AOh sensitization, increases the e.p.p., and antagonizes d-Tbc (Koketsu and Gerard,
1956), without being a depolarizer, or an anti-ChE agent, or
an unstabilizer of the nerve terminals. Finally, all these
three compounds are, in the frog, not only d-Tbc but also 0 1 0
antagonists.
1) It is of interest that, in the case of the frog isolated
nerve-muscle preparation, it is possible to compare the concentration found irulibitory to AChE in vitro, with the concentration effective pharmacologically. Usually, in vitro
data on anti-ChE action have to be correlated with in ~
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data, based on i.v. administration, and expressed in mg./kg.;
in view of the poor distribution of a bisquaternary compound
such as methoxyambenonium, such two sets of data are not really
comparable. Moreover, AChE inhibition, or its absence, upon
i.v. administration cannot be easily measured, at least manometrically, in the case of a reversible inhibitor such as
methoxyambenonium (cf. Koelle, 1961a, Karczmar, 1961), and,
in such experiments, the deduction as to whether or not methoxy
ambenonium acted as an AChE inhibitor, is difficult to assess.
The explanation of' these parao.oxical effects of NaF, TEA
and methoxyambenonium is difficult. It was already suggested
(Koketsu, 1958) that TEA increases the release of bound ACh
from the nerve terminals. This would then explain the phenomena observed by Koketsu (o.c.) as well as at present, such
as the increase and slight prolongation of the e.p.p., compared to the marked e.p.p. prolongation obtained with anti-ChE
agents; repetitive firing obtained with larger concentrations
of TEA; anti-d-Tbc action; and the fact that TEA particularly
effects the e.p.p. and the mechanical response obtained upon
the first few nerve stimulations. Furthermore, by assuming
this mechanism, the paradox of a substance which decreases ACh
sensitivity and yet is an anti-d-Tbo and anti-CIO agent is
resolved; the amplitude of the e.p.p. and the deblocking action
would be determined by two antagonistic actions of TEA: ACh
release and ACh desensitization (Table 1). Finally, the
present data on CIO antagonism of TEA are consistent both
with the view of d-Tbo-like action of CIO' and with the AChrelease mechanism of action of TEA.
It is more ditficul~ to suggest the mechanism of action
of methoxyambenonium and of NaF, besides pOinting out certain
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similarities and dissimilarities of their action. As shown
by Koketsu (l956) with regard to NeF, and as demonstrated at
present with regard to methoxyambenonium, neither agent produces augmentation of the mechanical muscle response to indirect
stimulation; both sensitize the e.p. to ACh, and both increase
the e.p.p_; they are not depolarizers or anti-ChE agents.
While HaP does not prolong ACh depolarization and the e.p.p.
as much as anti-ChE agents, yet it does so to a certain extent;
it resembles then in this respect ~EA, while methoxyambenonium
remains an unique agent in that it produces "augmentation
without prolongation" both with regard ,to the e.p.p. and to
ACh depolarization. Yet, Wal resembles methoxyambenonium (and
also TBl) in still another important respect, as shown at
present; it is not only en anti-curare but also an anti-CIO
agent. Koketsu (0.0.) presented some indirect evidenoe that
NaF does not inorease the release of ACh at the nerve terminal;
he proposed therefore that "BaP inoreases the affinity of ACh
for the e.p. membrane and enhances the depolarizing action of
ACh R (o.c.) by some specific, but hitherto unexplained,aotion.
In other words, it acts at the postsynaptic site as a sensitizer or facilitator.
It should be stressed that these terms are used here in
a sense more specific than that in which Perry (1956) used
them. Perry (o.c.), speaking of faoilitating compounds, had
in mind simply oompounds aoting 1n a manner different from
that of anti-ehB agents, but did not otherwise define their
aotion. In the light of the present researches, methoxyambenonium is a facilitator agent, sensitizing the e.p. to the
nerve impulse and to ACh; a facilitator can be defined therefore as a substanoe that augments, but does not prolong, the
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e.p.p. and AOh depolarization. This is a rare type of action,
hitherto not described.
In view of the similarities of action of NaP and mShoxyambenonium, and since neither is an anti-OhE or AOh-like
agent, these oompounds may be considered as facilitators.
It should be however remembered that, since methoxyambenonium
does not atfect the time course of AOh depolarization and of
e.p.p. which is somewhat prolonged by NaP, the mechanism of
action of methoxyambenonium and of Nal cannot be identical.
In any event, these views of action of metho~ambenonium,
HaF and TEA, coupled with the concept-y,alization that 0 10
blockade depends, like that of d-Tbc,upon ACh desensitization
or upon com.lJetition with AOh, may constitute a preliminary
picture of the antagonism between these agents and 010 •
d. Concluding remarks on CIO-methoxyambenonium
interplay.
~he above considerations lead to certain conclusions and
hypo~heses which can be summarized as follows.
In the frog as
in the oat, 0 10 blookade must conSist, to an extent at least,
of desensitizing the e.p. to ACh; this, ooupled with the
many instances of ACh-sensit1zing actions of methoxyambenoni~
at the e.p., shown at present, offers an explanation of its
effect upon 010 • Otherwise, metho~ambenonium antagonism of
both CIO and d-Tbc blockade in the cat, and in the frog cannot
be readily understood.
As already stated, this does not explain methoxyambenoni
"reversal tl of 010 and SOh blockade in the cat (Karozmar, 1957
and 1961). While the final explanation of the "reversal"
cannot be offered on the basis of these experiments, it may
be suggested that methoxyambenonium may prevent the desensi-
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tization or competition of 010 postsynaptic aotion (Table 1),
and synergize with oertain "facilitatory" actions of C10 •
The possible site and mechanism ot these "taoilitatory" aotions
of C10 will be discussed subsequently (seotion 2a of this Discu.ssion). Suffice it to say at present that these aotions
may be presynaptio and that methoxyambenonium may intensify
them at that site (Table 1). Methoxyambenonium may have then
two sites of action, postsynaptio and presynaptic. The f8ocilitatory poat-synaptio action of methoxyambenonium is amply documented at present, but its pre-synal~io effeot can be only
suggested. However, it may be speoulated that both these
effects are neoessary for the prediction of the 010 "reversal*'
by methoxyambenonium.
It may be also suggested that the action of methoxyambenonium is kept within "physiological" limits, because its
effects are not acoompanied by a prolongation of the a.p.p.
and of AOh depolarization, or by repetitive firing, and because
methoxyambenonium exhibits depressant properties when employed
at higher conoentration, suoh as decremental action upon AOh
depolarization and upon e.p.p. It should be stressed hare
that also TEA shows biphas10 aotions, and that this may contribute to its anti-010 action in the frog.
This may have also a bearing on the other problem, pointed
out above; namely the problem of the lack of antagonism - even
in the frog - between 010 and anti-OhE agents. Possibly these
agents lack a built-in safety factor. Also, lack of 010 antagonism by anti-ehE agents may be due, in some kind of a way,
to the contributory action of 010 depolarization. The depressant effect of anti-OhE agents on the e.p.p_ of 0lO-treated
neuromyal junctions should be also remembered in this context.

53.
More specifically, C depolarization, while not playing a
IO
conspicuous role in the blockade by C10 ' employed alone, may
be important in the presence of anti-ChE agents. In fact. increased depolarization was noticed at present in the case of
blocking combinations of CIO and eserine, or CIO and neostigmine; anti-ChE agents also produce depolarization, when used
alone in high concentrations (Douglas and Paton, 1954). Thus,
ChE inhibitors, by intensifying the depolarizing action of CIO '
can cause a pure depolarization blockade, such as suggested
by Zaimis (o.c.) for CIO alonejor, this component of combined
action of anti-ChE agents and C10 can contribute to e.p. desensitizing action of C10 It appears that TEA, NaF and methoxyambenonium antagonize
in the frog both d-Tbc and C10 • This can be partially explained
by the similarities in the d-Tbc and C10 blockade. This antagonism must be also based on a special characteristic of TEA,
HaF and methoxyambenonium, since so many other substances
cannot antagonize both the C10 and d-Tbc block. This aspect
of the action of these three agents may be their biphasic
effect, allowing them to limit undue C10 depolarization, or
it may depend on a "facilitatory" mechanism or mechanisms
different from the mechanism of action of anti-ChE's.
Altogether, this investigation, similar to other recent
analYSis of the pharmacology of the neuromyal junction (Riker
et al., 1959; Zaimis, 1959; Karczmar, 1961), indicate multiplicity of effects possible at the neuromyal junction. In
fact, they may serve to emphasize the warning of Bovet (1951)
that absolute distinction between agents active at the neuromyal junction is impossible. Indeed, causally committed terms
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such as "depolarizers" and "competitors" should be perhaps
avoided and each neuromyally active agent described in its
own right and in terms of its characteristic relationships
at the junction. Whether this state of matter exists because several sites of action are available within the neuromyal junction, or because receptor proteins may exhibit various
types of responses depending upon the presence of chemical
agents and on its physiological evironment, cannot be answered
at present.
2. Neuromyal actions of ACh and of CIO ' and their
mechanism.
One of the main aspects of the action of ACh emerging
from this research and from that of other investigators, is
the flexibility of this action.
Certain similar aspects of action of C were brought
IO
forward in ·~he course of this stud.y. In so far as ACh is concerned, it was found capable of at least three types of action
at the neuromyal junction, which in turn can be modulated by
the past history of the junction and by pharmacologic agents.
To start with, ACh exerted facilitatory actions, probably
u.nrelated to its depolarizing effect, as well ao blocking
effects upon the twitch of the indirectly stimulated muscle.
Secondly, adaptation to blocking concentrations of ACh seemed
possible, and, the neuromyal junction could be rendered insensitive to blocking concentrations of ACh by means of pretreatment with ACh. Finally - and this was brought up also
in the earlier section of this discussion - neuromyal actions
of ACh could be increased by agents other than anti-ChEfs
or releasers of ACh from nerve-end terminals, i.e. by facilitators.
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a. F.aoilitatory and blooking actions of ACh as
oompared with those of 010.
Weak concentrations of AOh increased the twitch response
of the muscle to indirect stimulation. ~his lasted for 5 to
15 minutes, i.e. over several trains of stimuli. Additionally,
similar twitch potentiation occurred after a muscle exposed to
blocking concentrations of ACh was washed out in Ringer; it is
conceivable that, even after several washes, traces of ACh rew.ained at the junction a.nd caused the potentiation.
It was shown at present that weak concentrations of 010
also produce facilitation, 010 resembl~ng in this respect AOh.
However, there seemed to exist some quantitative difference
between 010 and AOh. 010 facilitation could be much more
easily obtained than that by ACh. Also, in the case of suitable
doses, 010 could produce facilitation lasting up to 2 hrs.,
while ACh facilitation was temporary.
~he facilitatory actions of AOh and of CIO are not easy
to explain. fwitch potentiation by anti-ChE agents is generally
considered to be due to repetitive firing (cf. for instanoe,
Hastuk: and Alexander, 1954; ltarczmar and Fudema, 1957, and
Karczmar, 1961), i.e. to conversion of single twitches into
short tetani; similarly, AOh and CIO can produce repetitive
firing at the height of their depolarization. However, weak
facilitatory conoentrations of AOh and 010 certainly did not
produoe significant depolarization. In fact, the fac1litatory
actions of weak concentrations of AOh and of 0 10 continued,
in the case of present experiments, past the period of depolarization (figs. 11 and 17); they also could be obtained
with ooncentrations of ACh and of 010 incapable of significant
depolarization, as for instance when facilitation was noticed
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after ACh treatment, following several washes in saline. It
cannot be ruled out, however, that 0
and AOh could produce,
10
employed in concentrations in question, small, essentially not
measurable, depolarization. Nevertheless, it oannot be easily
explained why subthreshold depolarization should cause upon
indireot stimulation increased twitch amplitude.
It may be speoulated that 010 and AOh faoilitation are
analogous to post-tetanic faoilitation, and to facilitation
oocurring in the case of trains of stimuli. Fatt (1959) and
Dudel and Ruffler (1961) presented indireot evidence that these
types of faoilitation are due to incr~ased release, upon stimulation, of AOh from the nerve terminals when the terminals
are sensitized by earlier stimulation; this would be then a
reoruitment phenomenon, previous activity oausing more nerve
terminals to become active upon subsequent stimulation. Similarly, AOh and 010 oould produoe increased release of the endogenous transmitter from the nerve terminal. It should be added
that Koelle reoently (1961b) postulated on the basis of indireot evidence that, in the course of cholinergio synaptio
transmission, the stimulus arriving at the synapse oauses
"direot" release of small quantities of AOh, which then acts
upon the nerve terminals produoing a more massive release of
the transmitter. This suggestion is, in faot, related to the
earlier hypothesis of Masland and Wigton (1940) and of Riker
and his assooiates (1957, 1959), that certain ammonium ions
faoilitate and produce anti-d-Tbo action by a presynaptiC
facilitation at the nerve terminals. It was already suggested
in an earlier part of this discussion (cf. p. 62) that this
presynaptio action of CIO may underlie the CIO "reversal" by
methoxyambenonium.
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iu.Luther action of ACh that has been studied at present
i6 the blockade by this age'(lt. This blockade resembled in
some ways that by 010 but in other respects, differed from
C10 block. As in the case of CIO the depolarization was
temporary. Even in the case of strong concentrations of AOh,
and in continued presence of AOh, the membrane returned spontaneously to its normal potontial within 10 to 15 minutes;
this recovery was faster in the oase of weaker conoentrations.
Similar data were presented by Thesle!! (1955a and 1955b) and
Katz and Thesleff (1957). It was pointed out (Fatt, 1959)
that the neuromya.l jWlCtion, after being depolarized by ACh,
is not exoitable; altogether, the data suggest that, as in the
case of C10 ' AOh blockade is not due to depolarization.
In the case of higher concentrations, ACh blockade was
essentially irreversible, since it lasted from 2 to 4 hours,
thus resembling 010 blockade. On the other hand, recovery
from the blockade could be observed when weaker concentrations
of AOh were employed. In this case AOh block differed fromthat~
ClOt since even weaker concentrations of 010 , "'hich produced
early f&.oili tation, cau.sed subsequently irreversible, slowly
progressing blockade.
It could be that stronger, irreversibly blooking concentration of ACh, aa well as late phases of the progressive
C10 blockade, ma.y be due to changes in the muscle, as indicated
by the increase in muscle fiber resistance (Kim et al., unpublished). On the other hand, while reversible blocking
actions of \leaker cOllcentre.tlona of ACh as well as early
blocking actions of C10 do not depend on depolarization, they
may differ ill nature. As already stated, C10 blookade may
be competitive in character; on the other hand, weak concen-
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trations of ACh which cause blockade probably do no"t do so
competitively. This is suggested by the fact that both neostigmine and methoxyambenonium synergized with ACh in the production of blockade. It may be thought tlllit neostigmine, which
augments and prolo~;s ACh depolarization, as shown at present
and by other investit;ators (cf., for instance, Koketsu and
Gerard, 1956), san in this way synergize with ACh blookade.
Thus, AOh in combination with neostigmine may either produce
pure depolarization blockade, or cause increased desensitization. The same mechanism may obtain in the case of synergism between C
or SOh and anti-OhE ~ents, Observed at presen
10
in the frog and previously in the cat or dog (Karczmar, 1957
and 1961; cf. also p. 32). However, methoxyambenonium seems
even more synergistic with ACh than neostigmine. It synergized with ACh at concentrations lower than equi-effective concentrations of neostigmine; yet it is a much weaker anti-ChE
than neostigmine (Lands et al., 1955), and does not produce
prolongation of ACh depolarization. Moreover, oonoentrations
of ACh, oapable of blockade when oombined with subliminal ooncentrations of methoxyambenonium, did not produce, whether
used alone or with methoxyambenonium, any measurable depolarization. Thus, the synergism of methoxyambenonium with AOh
in the produotion of ACh blockade cannot be due to its antiOhE or depolarizing action.
Reoently, Smith (1960) also agreed that ACh blookade
oannot be due to depolarization; he speculated that AOh and/or
its hydrolysis products accumulate at the e.p. and oocupy it,
prev_nting diffusion to the e.p. of added ACh. The blockade
subliminal concentrations of ACh oombined with subliminal
by lL
conoentrations of metboxyambenonium seems to militate against
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"occupancy" theory of Smith; this ty.pe of block actually
suggests that ACh is capable of a desensitizing action; this
action could be, speculatively, due to ACh-induced reoeptor
change. It can be further speculated that, methoxyambenonium
can intensify ACh blockade not by inoreasing ACh depolarization
but by intensifying the postulated desensitizing action of
AOh at the receptor site.
On the other hand, this blocking aotion can be curaremimetic in nature, dependent upon competition, and thuB resemble, in the frog at least, 010 blockade. This may be borne
out by the fact that after ACh depola~ization is over and the
blockade ensues, higher concentrations of ACh are still capable
of producing depolarization. This is also consistent with the
fact that anti-ChE agents do not depolarize after AOh conditioning, since in a quiescent muscle no free ACh would be
available for the protective action of the anti-OhE compound.
Yet, one would expect that "sensitizing" or "facilitatory"
agents such as methoxyambenonium or NaF, should depolarize
the refractory e.p. when used in continued presence of ACh,
which was not the case. Altogether, it may be suggested that
AOh blockade is not depolarizing in nature, and it may be
speculated that it is not competitive in charaoter, but dependent upon other hitherto unknown factors.
b. Additional components of aotion of 010.
As already discussed, 010 blocks in the frog by desensitizing the e.p. to ACh or perhaps competing at the e.p. with
ACh. As a competitor t 010 may be displaoed by certain quaternary cations (Riker, 1953), including neostigmine. Competitive character of 010 blockade was also suggested by
Theslef! (1955a and b) on the basis of his data. Some results
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obtained here may be explained in a similar fashion. While
neostigmine in concentrations of lO-5M or higher intensified
CIO blockade, in weak concentrations it delayed the block
without decreasing its extent. This result cannot be due to
anti-ChE action of neostigmine, since this effect would contribute to rather than delay the blockade; it may be due, however,
to competition between C10 and neostigmine for the receptor
site. If the CIO blockade is co::npetitive in nature, it d.iffers
then from the ACh blockade if as speculated above, this blockade
is not competitive. It must be remembered however that strong
similarities - some suggested by the Dresent data, some shown
by other investigators - exist between CIO and ACh. Both exert
depolarizing actions. CIO' like ACh, causes twitch potentiatior
when used at low concentrations, &nd both cause blockade which,
in the frog at least, is independent of their depolarization.
It is a matter of ~~rther experimentation to ascertain whether
or not C10 blockade indeed differs from that produced by ACh.
c. Modulation of ACh action at the neuromyal
junction.
The foregOing underlin€d the flexibility of the response
of the neuromyal junction,exposed to ACh or to C10~to pharmacologic agents. The action of ACh, C
and SCh can be affected
10
by competiti~ely acting agents, anti-ChE compounds, unstabilizers of the nerve terminal (Riker et al. 1958), releasers
of ACh such as TEA,and by sensitizers. More than one type of
substance may belong to this latter category, since NaF action
differs in certain aspects from that of methoxyambenonium.
Another dimension of flexibility of action of ACh and of
C10 is added by the fact that they can act as facilitators and
also as blocking agents. The depolarizing action of ACh, just
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as that of C10 ' seems not to be the basis of their blocking or
facilitatory action.
Present experiments deal with changes occurring over long
time periods. ACh blockade occurs, in oontinued presenoe of
ACh, after 10 or 15 minutes-long depolarization. Somewhat similar da.ta were presented by Foldes (1959) a.nd Zaimis (1959)
Ao!,
indicating that, employed over extended time periods or upon~' i
repeated administration, C10 ceases depolarizing and acts as a
oompetitor of ACh, due presumably to a change in the reoeptor
protein. Yet, these long duration experiments may also oonstitute a wodel of immeasurably faster physiological events
oocurring at the e.p. If this is the case, the termination of
action of ACh upon each burst of stimuli way depend not only
upon ChE's, or upon diffusion, as suggested by Koelle (1959)
with regard to adrenergic transmitters, but upon a change in
the reoeptor reaotivity and aocompanying ohange in the mode of
aotion of ACh. Certain data by Del Castillo and Katz (19540)
obtained with iontophoretio techniques of ACh applioation may
suggest the OOOUl~anoe of similar phenomena~
The ohange in receptor protein under the impaot of ACh
seems to be the basis of the spontaneous recovery of the
neuromyal junction from blooking actions of ACh when the preparation is exposed to continued presence of ACh. Similar
changes may underlie the development of acute tolerance to
ACh of the junction whioh oan be demonstrated by "oonditioning"
of the e.p. to ACh. ACh was not previously considered as
exhibiting taohyphylaxis, althoUcih recovery from and adaptation
to high levels of ACh were reported before in the case of
sympathetic ganglia (Krivoy and Wills, 1956). Adaptation to
high doses of anti-ChE agents (Karczmar and Koppanyi. 1953;
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Barnes and Duff, 1953) presumably oonstitute similar phenomena.
Krivoyand Wills (0.0.) reported that ACh adaptation oocurs irre
speotive of maintenanoe of eleotronegativity due to the presenoe
of ACh at the ganglion. At the neuromyal junotion ACh depolarization does not persist in the oontinued presence of ACh; and
the adaptation to high levels of ACh may be due to the subsidence of depolarization and also to the faot that subsequent
additions of high levels of ACh lead to a relatively small depolarization. In other words, the neuromyal junction adapts
to a oertain level of ACh and responds not in relation to absolute ooncentrations of ACh, but rath~r to increments or
gradients of ACh.
The adaptation meohanism may act most importantly in
physiological processes of transmission by modulating these
prooesses~thus making it possible for the transmission to funoti n
,
in oertain states of hyper-release of ACh and produoing a buffer
effect in these situations. Suddenly inoreased conoentration
of ACh at a synapse will still produoe an effect even in continued presence of ACh derived from previous action; yet this ef
fect will not be undue or excessive.
The difference between CIO and ACh with regard to recovery
from and adaptation to their respeotive blockade is also of
interest in this context. Indeed, it may be teleologically
important that the natural transmitter, ACh, exhibits reversibility and tachyphylaxis while the exogenous substanoe, CIO '
does not. While these oonsiderations oan be only speoulative
and the mechanism of pertinent phenomena not available, these
differenoes between 010 and ACh bear stressing at this time.
,. Gen!ral conclusion~.
These investigations, both of actions of suoh pharma-

~
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cologic agents as 010' NaP, TEA and rnethoxyarnbenonium., as well
as of the oholinergic transmitter ACh, leave us with new facts,
mechanisms, and with certain speculations. It seems to be well
substantiated that certain new mechanisms, independent of such
better known mechanisms as anti-OhE and depolarizing action,
contribute to the effect of substances capable of deblocking
the neuromyal junction; among these new mec!~niSmB a specific
facilitator effect at the e.p. is described here for the
first time. These mechanisms as well as the non-depolarizing
aspects of 010 blockade provide the basis for the understanding
of the relatively few substances capa~le of antagonizing both
010 and d-Tbc blockade. This antagonism haa heretofore either
been poorly or not at all explained.
All this points to a flexibility of processes and multiplicity of sites at the neuromyal junction available for drug
action. Instead of thinking only in terms of depolarizing
and competitive and anti-OhE actions, we can also think of
releasers of AOh such as ~EA, as well as of facilitatory agents
such as NaF or metho~ambenonium. Finally, even the action
of AOh at the neuromyal junction may be speculatively resolved
into tacilitatory and blocking components. Furthermore, some
of the data here may suggest that neither of these aOtions
depends on the usual transmitter action of ACh, i.e. upon its
depolarizing property. This, plus the demonstrated recovery
and adaptation processes occurring at the neuromyal junction
with regard to the action of ACh, provides not only for the
flexibility of cholinergic transmission, but may be considered
as important in modulating cholinergic transmission and preserving its function in special phySiological conditions.

F.

Summax:y
I. Objectives and Methods
1. Tetraethylammonium (TEA), NaF, and methoxyambenoni
urn were studied with regard to their actions at the neuromyal
Junction, as well as with regard to their interaction with
C10 and d-tubocurarine (d-Tbc). Moreover, actions of CIO
and of acetylcholine (ACh) at the neuromyal junction were
com~red.

2. The purpose of the study was: 1) to explain the
antagonism of both d-Tbc and 010 by methoxyambenonium which is
diffioult to understand in the light ~f present theories of the
blocking action of d-Tbo and of 0lOi 2) to study the effects
of newer anti-d-Tbo agents, TEA and NaF, upon 010 blockade;
3) to compare these effects with those of anticholinesterase
agents; and 4) to explo~e whether AOh and CIO exert other than
depolarizing aotion at the neuromyal junction.
3. The study was carried out employing the mechanical
twitch response to indirect stimulation of the frog sartorius
muscle and measuring membrane phenomena such as endplate potential (e.p.p.), endplate and muscle membrane polarity, and
miniature endplate potentials (m.e.p.p.'s).
4. Mechanical muscle response was studied by means
of a force transducer and a polygraph. External and internal
micro-electrodes and oscillographio reoordings were employed
for the study of the membrane phenomena.
II. DrMa Effeots on the Meohanical Response of the Musole
to !ndirect Stimulation.
A. Eff,ot of methoxyambenonium, ambenonium •. and Na' on
muscle twitoh.
1. When supramaximal stimulation was used, methoxy-
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ambenonium did not increase the twitch amplitude at concentration of 5 x 10-7 to lO-5M. Higher concentrations caused
slowly developing blockade which was comulete within 30 to
50 minutes.
2. \,Ij'hen submaximal stimulation was employed, methoxyambenonium increased the twitch amplitude 20% to 40% above the
control level.
3. Ambenonium produced some blockade at 5 x lO-6M
concentrationj higher concentrations caused a more complete
blockade.
4. Employed at concentratio~8 of 0.3 to 1 x lO-3M,
TEA produced increase of muscle twitch amplitude on the first
stimulus of each train of stimuli both for supra- or sub-maximal stimulation.
B. Effects of methoxyambenonium, TEA and NaF uEPn C10
and d-Tbc blockade.
1. Methoxyambenonium produced partial restoration of
transmission blocked by C10 in the case of supramaximal stimUlation of intact nerve. More consistent antagonism between
CIO and methoxyambenonium (3 x 10- 6 to 1.5 x 10- 4M) occurred
with divided nerve or sub maximal stimulation.
2. TEA (3 x 10-4 to 10-3M) was more effective against
C10 than methoxyambenonium_
3. For submaximal stimUlation the muscle twitch depressed by C10 was augmented by TEA to an amplitude height
above that of controls obtained prior to CIO treatment. The
anti-C10 effect of TEA was especially pronounced in the case
of the first few responses, a.nd twitch amplitude subsequently
devreased.
4. NaF exhibited antagonistic action to the C10
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blookade of submaximal stimulation, but not supramaximal stimulation.
5. Anti-ChE agents, ambenonium (10- 7 to 10-5M), neostigmine (10- 6 to 5 x 10-5 M) and eserine (0.5 to 1.0 x lO-5 M),
used after the onset of CIO block, had no antagonistic effect
upon C10 blockade.
6. ~~en neostigmine was eml~yed in weak concentrations
simultaneously with 010, the onset of 010 blookade was delayed;
eserine did not exhibit this aotion.
7. A oombination of eserine (5 x 10-6M) and of methoxy
ambenonium oaused partial restoration;of transmission blocked
by 010 , even with supramaximal indirect stimulation.
s. ~iethoxyambenonium (1.0 to 2.0 x lO-6M) produoed
within a few minutes restoration of transmission blocked by
d-Tbo. iaster deblooking or intensification or original d-Tbo
blookade was notioed with stronger oonoentrations.
9. TEA in weaker ooncentration (3 to 5 x 10-4M) produoed restoration of transmission. With higher ooncentration
of 'fEA, the mechanioal responses were initially augmented and
then gradually depressed.
o. Effects of AOh and of 010 on Muscle Twitoh.
1. Generally AOh had depressant actions upon neuromyal transmission. After washing out the AOh, the twitch amplitude was inoreased above the control level. Faoilitation
sometimes ooourred also with weaker ooncentrations (lO-6M) of
AOh-following suoh a sequence.
2. 010 in weak concentrations (10- 5 to lO-~) exhibited ~ronounced and prolonged faoi11tatory effect on the trans
mission. "Treppe" wa.s alwa.ys noticed.

3. With weaker concentrations of AOh (5 x 10-6 to
lO-5M) which produced relatively small depression of transmission, spontaneous recovery could be observed. This did
not occur with higher concentrations of AOI1, or with both
low and high blocking concentrations of CIO ; in these instances, persistent blockade was noticed.
4. It was demonstrated that neuromuscular transmission can be conditioned to even higher concentrations of
ACh, or to AOh with neostigmine.
5. Subliminal concentrations of methoxyambenonium
(lO-7M) produced marked blockade when.added to subliminal concentrations of ACh (lO-~).
6. Adaptation or recovery phenomena were never notice
in the case of 0
blockade. lV-en with concentra.tions of CIO
10
causing initial facilitation (5 x 10- 6 to 6 x lO-5M), subsequunt blockade was progressive in nature.
III. Effects at the Endplate and on the MU,scle Membrane.
A. Interaction of HaF, TEA and methoxyambenonium with
d-Tbc and .910 •
1. It was determined that neither methoxyambenanium,
NaF, nor TEA had any effect on the resting potential of the
muscle fiber membrane or on the action potential of single
fibers.
2. Metho1yambenonium increased the amplitude of
m.e.p.p.'s but not their frequency. Eserine had no such
action.
3. Methoxyambenoniwn, NaIl' and TEA all increased the
e.p.p., whether the transmission was blOcked by d-Tbc or by
C10 •

68.

4. Anticholinesterase agents markedly prolonged the
e.p.p.. In the case of 0lO-blocked transmission, they frequently decreased the e.p.p. amplitude.
5. TEA and NaF prolonged e.p.p. slightly. Methoxyambenonium produced e.p.p. "augmentation without prolongation".
Methoxyambenonium is considered, therefore, a facilitator agent.
6. In high concentrations (10-4M), TEA produced repetitive firing whether the transmission was blocked with 0 10
or with d-Tbc. Methoxyambenonium was devoid of this action.
7. AOh depolarization of the endplate was increased
and prolonged by anti-cholinesterase agents. Methoxyambenonium
increased AOh depolarization without prolonging it at low
(10- 6 to 10-5M) concentrations and decreased it at higher concentrations (10- 5 to 10-4M).
8. TEA, in all effective concentrations (10- 5 to 10-4
M), decreased AOh depolarization.
B. Me9hanism of the an]agonism between 910 , and TiA
~d me~hoXlambenonium.

1. C10 depolarized the a.p., but the blockade of
transmission bega.n after the peak depolarization was reached;
the block to indirect stimulation increased and persisted
after the der)olarization was over. This is in confirmation
of earlier data of Thesleff (19558. and b).
2. 010 desensitized the endplate to AOh, which again
confirms the data of Thesleff. This effect could be reversed
by methoxyambenonium (10- 6 to 10-5M), but ACh desensitization
was intensified by a.ll effective concentrations of TEA.
;. C10 and d-Tbc synergized in blocking the transmission and decreasing the e.p.p.
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4. Both methoxyambenonium (5 x 10-5 to 10-6M) and T
(0.1 to 0.5 x 10-4M) increased the e.p.p. obtained in the presence of d-Tbc and C •
IO
o. Etf!cys of ACh.
1. ACh depolarization, similarly to that by C10 '
runs a time course which is not parallel with AOh blookade of
neuromyal transmission.
2. After AOh depolarization oeased, and before neuro
myal transmission was restored, the endplate was depolarized
to a small extent by higher oonoentrations of ACh. This confirms earlier data of Del Castillo and Katz (1954a).
3. The endplate, desensitized by ACh, could not be
depolarized again by eserine or methoxyambenonium in oontinued
presence of AOh.
4. The highest degree of depolarization of desensitized endplate was obtained by employment of AOh combined with
weak (10-6M) concentration of methoxyambenonium.
IV. Conclusions and hypotheses.
1. One of the reasons why NaF. TEA, and methoxyambenonium can antagonize both C10 and d-Tbc block of the frog
nerve-muscle .preparation must be t.bat ClOt like d-Tbo, blocks
mainly by desensitizing the endplate to ACh.
2. NaF and methoxyambenonium are faoilitatory compounds, distinct from anticholinesterase agents. TEA antagonizes d-Tbc and 010 possibly by releasing ACh trom motor
nerve terminals.
3. Speculation as to why NaF, TEA, and methoxyambeno
nium (but not anticholinesterase agents) antagonize 010' must
relate to the fact that anticholinesteraaea do not increase
e.p •.• of the endplate blocked by CIO • This may be due to

70.

intensification of the depolarizing action of CIO by anticholinesterases.
4. CIO "reversal" by methoxyambenonium may be explained on the basis of two actions of the latter: A) the
facilitating postsynaptic a.ction, demonstrated here which antagonizes CIO desensitization of the endplate, and B) intensifying action of me"thoxyarubenonium on "the i:Jresynaptic component of CIO action, leading to the increase of twitch amplitude.
5. Flexibility of the neuromyal transmission is well
expressed by diversified actions and mechanisms of action of
agents studied here. Even CIO and ACh actions at the neuromyal junction differ.
6. Another dimension of flexibility of the neuromyal junction is ex~ressed by the fact that neuromyal transmission can be conditioned to high concentrations of ACh, and
may recover from ACh blockade.
7. Physiological significa.nce of these findings
is discussed.
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Fig. 1:
Blocking effect of high concentrationLl of methoxyambenonium (WIN 8078, 7 x 10-5 ri1) upon neuromyal transmission.
Frog sartorius muscle stimulated indirectly. Cf. Viethods for
details of technique.
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Twitch response of frog sartorius to stimulation of
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neuromyal transmission blocked. by C10 (5 x 10-6M). Other
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Partial antagonism between TEA and C10 (7.5 x lO-5 M).
Responses to supramaximal nerve stimulation. Note particularly
the increased amplitude of the first muscle response after TEA.
Cf. also fig. 1.
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secondary facilitation.
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Fig. 12: Recovery of neuromyal transmission after blockade by
acetylcholine.
Consecutive records, at time intervals indicated, of the twitch amplitude of indirectly stimulated sartorius muscle in acetylcholine (ACh, 5 x lO-6M). Fresh solution
of acetylcholine employed every 5 minutes. Supramaximal stimulation.
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Plot of spontaneous recovery of neuromyal transmission from partial blockade induced by acetylcholine (ACh,
7 x lO-6Mj crosses and dashed line), and by acetylcholineneostigmine combination (ACh, 2 x lO-8M with NST, 1 x lO-6Mj
circles and continuous line). Abscissae:
time in minutes;
ordinate:
twitch amplitude in percent of the control twitch.
The experiment dealing with recovery from ACh is different
from the one illustrated in fig. 12.
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Fig. 20:
Effect of methoxyambenonium (WIN 8078, 5 x 10-6M)
upon the amplitude of the miniature endplate potentials
(m.e.p.p. 's). Notice that eserine had$r~teffect, and that
the amplitude rather than frequency of m.e.p.p.'s was increased by methoxyambenonium. Each record shows from 6 to
8 sweeps (rate of the sweep 2ms/cm; approximate time interval
between sweeps 0.1-0.2 sec.) on the oscilloscope screen.
For
further details on techniques, cf. Methods.
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Fig. 21: Augmentator~ (facilitatory) effect of methoxyambenonium (WIN 8078, 10-6M) upon endplate potential (a.p.p.) of
curarized frog nerve-muscle preparation. Lower and upper
tracings, A.C. and D.C. recordings, respectively_ Shock
artefact visible in each tracing. Cf. also Methods.

Fi~. 22:

Effect of TEA, lO-4M, upon endplate potential (e.p.p.)
of nerve-muscle preparation. Transmission blocked by ClOt
5 x 10-5 M (upper record). Four super1mposable e.p.p.'s recorded. Lower record, two tracings 5 minutes after TEA.
First tracing illustrates prolongation of e.p.p. by TEA. The
very next sweep (after 0.1 sec.) shows spikes and repetitive
firing. Cf. also Methods and Text.

CONTROL E.P.P.
C-IO
5XIO- 7

CONTROL E. P. P.
D-TBC
3X10- S

CONTROL E.P'P.
C-IO
IXIO-6

" MIN AFTER
WIN 8078 ~XIO-S

:15 MIN AFTER
S
ESERINE 3X10-

20 MIN
ESERINE

AFTER
3XI0-6

Fig. 2~: The effects of va.rious chemical agents upon the e.p.
p. Molar concentrations throughout. Top-row: the effect of
methoxyambenonium (WIN 8078) upon the e.p.p. after the blockade
of transmission by C10. Observe that single spike seemed to
have been induced by methoxyambenonium; note also that methoxyambenonium caused "augmentation without prolongation" of the
e.p.p. Middle-~: the effect of physostigmine (eserine) upon
the e.p.p. of the curarized preparation. Note the conspicuous
prolongation of the e.p.p. by physostigmine. Bottom-row: the
effect of physostigmine upon a.p •. p. produced by 010- Note that
the control a.p.p. is at a threshold level of depola.rization
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The effect of rnethoxyarnbenonium (WIN 8078) upon
depolarization by acetylcholine (ACh) , diminished by CIO.
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IO
and continuous line). After wash in Ringer, essentially similar depolarization was obtained by CIO, 5 x 10-5 M, and WIN
8078, 10-5M, employed simultaneously (crosses and dashed line).
After appropriate wash in Ringer, ACh (5 x 10-5M) depolarizatio
was measured (semi-empty circles and continuous line); followi
wash in Ringer and treatment with CIO (5 x 10-5 M), ACh depolari
zation was diminished (empty circles and continuous line),
finally, after one more wash, combined treatment with CIO,
ACh and WIN 8078 (5 x 10-5 M in each case) caused increased
depolarization (full circle and continous line). External
electrodes.
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tig. 21: Biphasic effect of methoxyambenonium (WIN 8078)
upon acetylcholine (ACh) depolarization, The preparation
was exposed first to lOh alone, then to ACh and weak
concentrati~n of WiN 8078, and, finally, to AOh and strong
concentration of WIN 8078. The preparation was washed in
Ringer between treatments. External electrodes. Other
explanations in the figure and in the text.
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Fig. 28: Augmentation and prolongation of acetylcholine
(ACh) depolarization by eserine. The neuromyal preparation
was first exposed to ACh alone, and then, after appropriate
wash in Ringer, to ACh and eserine. External electrodes
recording.
Other explanation in the figures and in the text.
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Fig. 29:
Lack of effect of TEA upon acetylcholine (ACh) depolarization reduced by CIO treatment. C
depolarization
IO
was first measured with (dots and thin line) and without
(full circles and dashed line) TEA; TEA seemed to increase
somewhat CIO depolarization. Subsequently, ACh depolarization
was measured with (full circles and continuous line, lower
part of the i~lustration) and Iii thout (full circles and thick
line) CIO' Addition of TEA did not increase ACh depolarization
in presence of CIO (full circles and thin line, lower part of
the figure).
Appropriate washes after each treatment. External electrodes recording.
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Fig. 30: Effect of acetylcholine (ACh) upon the endplate and
neuromyal transmission. Upper record, recording of muscle
twitch (indirect st mulation). Lower record, depolarization
due to ACh (5 x 10- M), measured with external electrodes.
Identical sc~les (minutes) for the measurement of depolarization and of the muscle twitch. Note that partial ACh
blockade developed after the peak depolarization, and persisted for some time after depolarization was over (15-20
minutes).
Spontaneous recovery of transmission (25 - 30
minutes) without further change of the endplate membrane.
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Fig. 31:
Desensitization of the endplate by acetylcholine
(ACh, 5 x 10-5M). After ACh depolarization (circles and continuous line) was over, eserine (5 x 10-6M) had no depolarizing
action in continued presence of ACh, while strong concentration
of ACh, and particularly, combined treatment with weak concentrations of ACh (5 x 10-6M) and of methoxyambenonium (WIN
8078, 5 x 10- 61\11) were effective (full circles and continuous
line).
External electrodes recording. Other explanations in
the figure.
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Fig. 32:
Desensitization of the endplate by acetylcholine
(ACh, 5 x 10-6M). After ACh depolarization was over, addition
of 10 times more concentrated ACh solution caused some depolarization.
External electrodes. Other explanations in
the text.
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